2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

[1]  J. Navia,et al.  Transcatheter Tricuspid Valve Interventions: Landscape, Challenges, and Future Directions. , 2018, Journal of the American College of Cardiology.

[2]  B. Nordestgaard,et al.  Genetic variation in clusterin and risk of dementia and ischemic vascular disease in the general population: cohort studies and meta-analyses of 362,338 individuals , 2018, BMC Medicine.

[3]  D. Reboussin,et al.  Systematic Review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2017, Journal of the American College of Cardiology.

[4]  S. Daniels,et al.  Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents , 2017, Pediatrics.

[5]  James R. Powell,et al.  Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized Trial , 2017, Diabetes Care.

[6]  Gerasimos S Filippatos,et al.  2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. , 2017, Journal of the American College of Cardiology.

[7]  E. O’Brien,et al.  The pursuit of accurate blood pressure measurement: A 35‐year travail , 2017, Journal of clinical hypertension.

[8]  Pavel S. Roshanov,et al.  Withholding versus Continuing Angiotensin-converting Enzyme Inhibitors or Angiotensin II Receptor Blockers before Noncardiac Surgery: An Analysis of the Vascular events In noncardiac Surgery patIents cOhort evaluatioN Prospective Cohort , 2017, Anesthesiology.

[9]  P. Whelton,et al.  Systolic Blood Pressure Reduction and Risk of Cardiovascular Disease and Mortality: A Systematic Review and Network Meta-analysis , 2017, JAMA cardiology.

[10]  Yuqing Zhang,et al.  Comparative efficacy of β-blockers on mortality and cardiovascular outcomes in patients with hypertension: a systematic review and network meta-analysis. , 2017, Journal of the American Society of Hypertension : JASH.

[11]  C. Agyemang,et al.  Thresholds for Ambulatory Blood Pressure Among African Americans in the Jackson Heart Study , 2017, Circulation.

[12]  L. Fleisher,et al.  2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2017, Journal of the American College of Cardiology.

[13]  S. Bangalore,et al.  Optimal Systolic Blood Pressure Target After SPRINT: Insights from a Network Meta-Analysis of Randomized Trials. , 2017, The American journal of medicine.

[14]  M. Gulati.  Early Identification of Pregnant Women at Risk for Preeclampsia: USPSTF Recommendations on Screening for Preeclampsia. , 2017, JAMA cardiology.

[15]  P. Whelton,et al.  Using Predicted Cardiovascular Disease Risk in Conjunction With Blood Pressure to Guide Antihypertensive Medication Treatment. , 2017, Journal of the American College of Cardiology.

[16]  Lawrence A Leiter,et al.  Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults. , 2017, The Canadian journal of cardiology.

[17]  Jillian T Henderson,et al.  Preeclampsia Screening: Evidence Report and Systematic Review for the US Preventive Services Task Force , 2017, JAMA.

[18]  S. Hazen,et al.  Gut Microbiota in Cardiovascular Health and Disease , 2017, Circulation research.

[19]  Emmanuel O Nketiah,et al.  Cardiac electrical biomarker response during percutaneous coronary intervention , 2017 .

[20]  T. Wilt,et al.  Pharmacologic Treatment of Hypertension in Adults Aged 60 Years or Older to Higher Versus Lower Blood Pressure Targets: A Clinical Practice Guideline From the American College of Physicians and the American Academy of Family Physicians , 2017, Annals of Internal Medicine.

[21]  L. Fleisher,et al.  2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2017, Journal of the American College of Cardiology.

[22]  M. Fornage,et al.  Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association , 2017, Circulation.

[23]  D. Lloyd‐Jones,et al.  Global Risk Assessment to Guide Blood Pressure Management in Cardiovascular Disease Prevention , 2017, Hypertension.

[24]  Federica Violi,et al.  The effect of potassium supplementation on blood pressure in hypertensive subjects: A systematic review and meta-analysis. , 2017, International journal of cardiology.

[25]  S. Bangalore,et al.  Outcomes of Intensive Blood Pressure Lowering in Older Hypertensive Patients. , 2017, Journal of the American College of Cardiology.

[26]  J. Rehm,et al.  The effect of a reduction in alcohol consumption on blood pressure: a systematic review and meta-analysis. , 2017, The Lancet. Public health.

[27]  J. Schwartz,et al.  Prevalence of Masked Hypertension Among US Adults With Nonelevated Clinic Blood Pressure , 2017, American journal of epidemiology.

[28]  D. Kansagara,et al.  Benefits and Harms of Intensive Blood Pressure Treatment in Adults Aged 60 Years or Older , 2017, Annals of Internal Medicine.

[29]  Ivy Shiue,et al.  Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015 , 2017, JAMA.

[30]  A. Chobanian,et al.  Guidelines for the Management of Hypertension. , 2017, The Medical clinics of North America.

[31]  A. Dominiczak,et al.  Hypertension: Update 2017. , 2017, Hypertension.

[32]  R. Freeman,et al.  The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension , 2017, Journal of Neurology.

[33]  P. Whelton,et al.  Effectiveness of Chlorthalidone Plus Amiloride for the Prevention of Hypertension: The PREVER‐Prevention Randomized Clinical Trial , 2016, Journal of the American Heart Association.

[34]  E. O’Brien,et al.  The Cardiovascular Risk of White-Coat Hypertension. , 2016, Journal of the American College of Cardiology.

[35]  M. Vinceti,et al.  Meta‐Analysis of Potassium Intake and the Risk of Stroke , 2016, Journal of the American Heart Association.

[36]  M. Walsh,et al.  Women, Hypertension, and the Systolic Blood Pressure Intervention Trial. , 2016, The American journal of medicine.

[37]  N. Cook,et al.  Salt Sensitivity of Blood Pressure: A Scientific Statement From the American Heart Association. , 2016, Hypertension.

[38]  Rui Chen,et al.  CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea. , 2016, The New England journal of medicine.

[39]  J. Staessen,et al.  Evaluation of Adherence Should Become an Integral Part of Assessment of Patients With Apparently Treatment-Resistant Hypertension , 2016, Hypertension.

[40]  Yiqing Song,et al.  Effects of Magnesium Supplementation on Blood Pressure: A Meta-Analysis of Randomized Double-Blind Placebo-Controlled Trials. , 2016, Hypertension.

[41]  G. Reboldi,et al.  More Versus Less Intensive Blood Pressure-Lowering Strategy: Cumulative Evidence and Trial Sequential Analysis. , 2016, Hypertension.

[42]  Lenore J Launer,et al.  Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial. , 2016, JAMA.

[43]  B. Hemmelgarn,et al.  The Effectiveness of Pharmacist Interventions on Cardiovascular Risk: The Multicenter Randomized Controlled RxEACH Trial. , 2016, Journal of the American College of Cardiology.

[44]  D. Hanley,et al.  Intensive Blood-Pressure Lowering in Patients with Acute Cerebral Hemorrhage. , 2016, The New England journal of medicine.

[45]  J. Coresh,et al.  Antihypertensive Medications and the Prevalence of Hyperkalemia in a Large Health System , 2016, Hypertension.

[46]  K. Kalantar-Zadeh,et al.  Age and Outcomes Associated with BP in Patients with Incident CKD. , 2016, Clinical journal of the American Society of Nephrology : CJASN.

[47]  R. Sequeira,et al.  Antihypertensive Drugs and Male Sexual Dysfunction , 2016, Journal of cardiovascular pharmacology and therapeutics.

[48]  Mahboob Rahman,et al.  Masked Hypertension and Elevated Nighttime Blood Pressure in CKD: Prevalence and Association with Target Organ Damage. , 2016, Clinical journal of the American Society of Nephrology : CJASN.

[49]  P. Lam,et al.  ACUTE MANAGEMENT OF INTERVENTRICULAR SEPTAL HEMATOMA AFTER AN ST-ELEVATION MYOCARDIAL INFARCTION IN THE SETTING OF RECENT SUBDURAL HEMATOMA , 2016 .

[50]  J. Cigarroa,et al.  Further Evolution of the ACC/AHA Clinical Practice Guideline Recommendation Classification System: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2016, Circulation.

[51]  S. Yusuf,et al.  Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease. , 2016, The New England journal of medicine.

[52]  D. Andreini,et al.  COMPUTED TOMOGRAPHY CORONARY ANGIOGRAPHY VERSUS STRESS CARDIAC MAGNETIC RESONANCE FOR THE MANAGEMENT OF SYMPTOMATIC REVASCULARIZED PATIENTS: A COST EFFECTIVENESS STUDY (STRATEGY STUDY) , 2016 .

[53]  G. Parati,et al.  Effects of blood pressure lowering on outcome incidence in hypertension: 7. Effects of more vs. less intensive blood pressure lowering and different achieved blood pressure levels – updated overview and meta-analyses of randomized trials , 2016, Journal of hypertension.

[54]  D. Tousoulis,et al.  White-coat hypertension and cardiovascular events: a meta-analysis , 2016, Journal of hypertension.

[55]  M. Jaffe,et al.  The Kaiser Permanente Northern California Story: Improving Hypertension Control From 44% to 90% in 13 Years (2000 to 2013) , 2016, Journal of clinical hypertension.

[56]  C. Chiang,et al.  Comparative Effectiveness of Blood Pressure-lowering Drugs in Patients who have Already Suffered From Stroke , 2016, Medicine.

[57]  S. Bergese,et al.  Perioperative Use of Clevidipine: A Systematic Review and Meta-Analysis , 2016, PloS one.

[58]  J. Coresh,et al.  Race, APOL1 Risk, and eGFR Decline in the General Population. , 2016, Journal of the American Society of Nephrology : JASN.

[59]  S. Anderson,et al.  Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis , 2016, The Lancet.

[60]  W. Young,et al.  The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline. , 2016, The Journal of clinical endocrinology and metabolism.

[61]  M. Hill,et al.  Expanding the Role of Nurses to Improve Hypertension Care and Control Globally. , 2016, Annals of global health.

[62]  P. Elliott,et al.  An Update on Nutrients and Blood Pressure. , 2016, Journal of atherosclerosis and thrombosis.

[63]  Á. Gava,et al.  Novel Therapeutic Targets for Phosphodiesterase 5 Inhibitors: current state-of-the-art on systemic arterial hypertension and atherosclerosis. , 2016, Current pharmaceutical biotechnology.

[64]  Bo Carlberg,et al.  Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses , 2016 .

[65]  G. Watts.  Xueqing Yu: a driving force in Chinese nephrology , 2016, The Lancet.

[66]  P. Nilsson,et al.  DPP-4 inhibition and blood pressure lowering in perspective. , 2016, Journal of hypertension.

[67]  K. Sink,et al.  Hypertension and Its Role in Cognitive Function: Current Evidence and Challenges for the Future. , 2016, American journal of hypertension.

[68]  N. Smart,et al.  Isometric exercise training for blood pressure management: a systematic review and meta-analysis to optimize benefit , 2016, Hypertension Research.

[69]  M. Woodward,et al.  Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis , 2016, The Lancet.

[70]  Mark D. Huffman,et al.  Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association , 2016, Circulation.

[71]  A. Murray,et al.  Comparison of stethoscope bell and diaphragm, and of stethoscope tube length, for clinical blood pressure measurement , 2016, Blood pressure monitoring.

[72]  Ashutosh Kumar Singh,et al.  Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 , 2016, Lancet.

[73]  C. Escobar Cervantes,et al.  [A randomized trial of intensive versus standard blood pressure control]. , 2016, Semergen.

[74]  Jackson T. Wright,et al.  A Randomized Trial of Intensive versus Standard Blood-Pressure Control. , 2016, The New England journal of medicine.

[75]  Linnea A. Polgreen,et al.  Cost-Effectiveness of a Physician–Pharmacist Collaboration Intervention to Improve Blood Pressure Control , 2015, Hypertension.

[76]  D. Goff,et al.  Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Diabetes Mellitus: Action to Control Cardiovascular Risk in Diabetes Blood Pressure Trial. , 2015, Hypertension.

[77]  Haitham M. Ahmed,et al.  US Hypertension Management Guidelines: A Review of the Recent Past and Recommendations for the Future , 2015, Journal of the American Heart Association.

[78]  A. Rodgers,et al.  Redefining Blood-Pressure Targets--SPRINT Starts the Marathon. , 2015, The New England journal of medicine.

[79]  Isla Mackenzie,et al.  Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial , 2015, The Lancet.

[80]  A. Khera,et al.  Target Organ Complications and Cardiovascular Events Associated With Masked Hypertension and White-Coat Hypertension: Analysis From the Dallas Heart Study. , 2015, Journal of the American College of Cardiology.

[81]  A. Siu.  Screening for high blood pressure in adults: U.S. Preventive Services Task Force recommendation statement. , 2015, Annals of internal medicine.

[82]  M. Walsh,et al.  The role of the clinical pharmacist in the care of patients with cardiovascular disease. , 2015, Journal of the American College of Cardiology.

[83]  M. Carroll,et al.  Hypertension Prevalence and Control Among Adults: United States, 2011-2014. , 2015, NCHS data brief.

[84]  Khagendra Dahal,et al.  The Effects of Aldosterone Antagonists in Patients With Resistant Hypertension: A Meta-Analysis of Randomized and Nonrandomized Studies. , 2015, American journal of hypertension.

[85]  Di Zhao,et al.  Prevention of atrial fibrillation with renin-angiotensin system inhibitors on essential hypertensive patients: a meta-analysis of randomized controlled trials , 2015, Journal of biomedical research.

[86]  S. Manaker..  Time to Get Off the Diagnosis Dime Onto the 10th Revision of the International Classification of Diseases , 2015, Annals of Internal Medicine.

[87]  B. Spring,et al.  Current Science on Consumer Use of Mobile Health for Cardiovascular Disease Prevention: A Scientific Statement From the American Heart Association. , 2015, Circulation.

[88]  M. Prince,et al.  World Alzheimer Report 2015 - The Global Impact of Dementia: An analysis of prevalence, incidence, cost and trends , 2015 .

[89]  J. Roy,et al.  Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitor-Based Treatment on Cardiovascular Outcomes in Hypertensive Blacks Versus Whites. , 2015, Journal of the American College of Cardiology.

[90]  Dan J Stein,et al.  Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, BDJ.

[91]  Amanda F. Petrik,et al.  Systolic BP and Mortality in Older Adults with CKD. , 2015, Clinical journal of the American Society of Nephrology : CJASN.

[92]  George Davey-Smith,et al.  Social Determinants of Risk and Outcomes for Cardiovascular Disease: A Scientific Statement From the American Heart Association , 2015, Circulation.

[93]  Z. Jing,et al.  Prognostic Impact of Blood Pressure Variability on Aortic Dissection Patients After Endovascular Therapy , 2015, Medicine.

[94]  N. Ohte,et al.  Dietary Sodium Consumption Predicts Future Blood Pressure and Incident Hypertension in the Japanese Normotensive General Population , 2015, Journal of the American Heart Association.

[95]  Alan B Leichtman,et al.  US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[96]  P. Dubbert,et al.  Prevalence, Determinants, and Clinical Significance of Masked Hypertension in a Population-Based Sample of African Americans: The Jackson Heart Study. , 2015, American journal of hypertension.

[97]  A. Ciapponi,et al.  Calcium supplementation for prevention of primary hypertension. , 2015, The Cochrane database of systematic reviews.

[98]  S. Navaneethan,et al.  Cause-Specific Deaths in Non-Dialysis-Dependent CKD. , 2015, Journal of the American Society of Nephrology : JASN.

[99]  Rong Zhao,et al.  Blood Pressure Reduction in the Acute Phase of an Ischemic Stroke Does Not Improve Short- or Long-Term Dependency or Mortality , 2015, Medicine.

[100]  M. Tonelli,et al.  Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis , 2015, The Lancet.

[101]  Jane A. Linderbaum,et al.  2015 ACC Health Policy Statement on Cardiovascular Team-Based Care and the Role of Advanced Practice Providers. , 2015, Journal of the American College of Cardiology.

[102]  Christopher M O'Connor,et al.  Treatment of Hypertension in Patients With Coronary Artery Disease: A Scientific Statement From the American Heart Association, American College of Cardiology, and American Society of Hypertension , 2015, Hypertension.

[103]  L. Afonso,et al.  Left ventricular hypertrophy and risk reclassification for coronary events in multi-ethnic adults , 2015, European journal of preventive cardiology.

[104]  J. Stehli,et al.  First experience with single-source, dual-energy CCTA for monochromatic stent imaging. , 2015, European heart journal cardiovascular Imaging.

[105]  E. Reisin,et al.  Anti-hypertensive Drug Treatment of Patients with and the Metabolic Syndrome and Obesity: a Review of Evidence, Meta-Analysis, Post hoc and Guidelines Publications , 2015, Current Hypertension Reports.

[106]  E. Muxfeldt,et al.  Effects of Continuous Positive Airway Pressure Treatment on Clinic and Ambulatory Blood Pressures in Patients With Obstructive Sleep Apnea and Resistant Hypertension: A Randomized Controlled Trial , 2015, Hypertension.

[107]  T. Vaughn,et al.  Cluster-Randomized Trial of a Physician/Pharmacist Collaborative Model to Improve Blood Pressure Control , 2015, Circulation. Cardiovascular quality and outcomes.

[108]  B. Prendergast,et al.  A prospective, double-blind, randomized controlled trial of the angiotensin-converting enzyme inhibitor Ramipril In Aortic Stenosis (RIAS trial) , 2015, European heart journal cardiovascular Imaging.

[109]  Stefano Omboni,et al.  The Role of Telemedicine in Hypertension Management: Focus on Blood Pressure Telemonitoring , 2015, Current Hypertension Reports.

[110]  P. Whelton,et al.  The elusiveness of population-wide high blood pressure control. , 2015, Annual review of public health.

[111]  A. Dominiczak,et al.  Genetic and molecular aspects of hypertension. , 2015, Circulation research.

[112]  S. Mayor.  Brain training, exercise, and healthy eating slow cognitive decline in elderly people at risk, study finds , 2015, BMJ : British Medical Journal.

[113]  H. Kramer,et al.  The Western Diet and Chronic Kidney Disease , 2015, Current Hypertension Reports.

[114]  S. Frey,et al.  Systematic review and meta-analysis of the prevalence of resistant hypertension in treated hypertensive populations. , 2015, American journal of hypertension.

[115]  H. Bucher,et al.  A systematic review and metaanalysis on the effects of garlic preparations on blood pressure in individuals with hypertension. , 2015, American journal of hypertension.

[116]  C. Rodriguez,et al.  Prevalence and trends of isolated systolic hypertension among untreated adults in the United States. , 2015, Journal of the American Society of Hypertension : JASH.

[117]  B. Mol,et al.  Cardiovascular Disease Risk Factors After Early-Onset Preeclampsia, Late-Onset Preeclampsia, and Pregnancy-Induced Hypertension , 2015, Hypertension.

[118]  S. Angell,et al.  Self-Blood Pressure Monitoring in an Urban, Ethnically Diverse Population: A Randomized Clinical Trial Utilizing the Electronic Health Record , 2015, Circulation. Cardiovascular quality and outcomes.

[119]  G. Lipkin,et al.  Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in women of childbearing age: risks versus benefits , 2015, Expert review of clinical pharmacology.

[120]  H. Minakami,et al.  Outcomes of 83 fetuses exposed to angiotensin receptor blockers during the second or third trimesters: a literature review , 2015, Hypertension Research.

[121]  K. Rahimi,et al.  Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis. , 2015, JAMA.

[122]  A. Turchin,et al.  Optimal systolic blood pressure target, time to intensification, and time to follow-up in treatment of hypertension: population based retrospective cohort study , 2015, BMJ : British Medical Journal.

[123]  M. Woodward,et al.  Effects of blood pressure reduction in mild hypertension: a systematic review and meta-analysis. , 2015, Annals of internal medicine.

[124]  Evelyn P Whitlock,et al.  Diagnostic and Predictive Accuracy of Blood Pressure Screening Methods With Consideration of Rescreening Intervals: A Systematic Review for the U.S. Preventive Services Task Force , 2015, Annals of Internal Medicine.

[125]  E. Reisin,et al.  Treatment: special conditions. Metabolic syndrome: obesity and the hypertension connection. , 2015, Journal of the American Society of Hypertension : JASH.

[126]  G. Parati,et al.  Effects of blood pressure lowering on outcome incidence in hypertension: 4. Effects of various classes of antihypertensive drugs – Overview and meta-analyses , 2015, Journal of hypertension.

[127]  Dingli Xu,et al.  Prehypertension and the Risk of Coronary Heart Disease in Asian and Western Populations: A Meta‐analysis , 2015, Journal of the American Heart Association.

[128]  R. Vasan,et al.  Clinical Correlates and Prognostic Significance of Change in Standardized Left Ventricular Mass in a Community‐Based Cohort of African Americans , 2015, Journal of the American Heart Association.

[129]  B. Hawkins,et al.  Blood pressure control for diabetic retinopathy. , 2015, The Cochrane database of systematic reviews.

[130]  J. Singer,et al.  Less-tight versus tight control of hypertension in pregnancy. , 2015, The New England journal of medicine.

[131]  E. Sanidas,et al.  Cardiovascular Hypertensive Emergencies , 2015, Current Hypertension Reports.

[132]  E. Sheiner,et al.  Long-term maternal atherosclerotic morbidity in women with pre-eclampsia , 2015, Heart.

[133]  Akshay S. Desai,et al.  Regional Variation in Patients and Outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial , 2015, Circulation.

[134]  Yuling Hong,et al.  Trends in Blood Pressure Among Adults With Hypertension: United States, 2003 to 2012 , 2015, Hypertension.

[135]  Tobias Schaeffter,et al.  Altered Dependence of Aortic Pulse Wave Velocity on Transmural Pressure in Hypertension Revealing Structural Change in the Aortic Wall , 2014, Hypertension.

[136]  M. Rocco,et al.  Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial , 2014, Kidney international.

[137]  E. Soliman,et al.  Left ventricular hypertrophy and cardiovascular disease risk prediction and reclassification in blacks and whites: the Atherosclerosis Risk in Communities Study. , 2015, American heart journal.

[138]  M. Woodward,et al.  Predicting the effects of blood pressure-lowering treatment on major cardiovascular events for individual patients with type 2 diabetes mellitus: results from Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation. , 2015, Hypertension.

[139]  Kaleab Z. Abebe,et al.  Blood pressure in early autosomal dominant polycystic kidney disease. , 2014, The New England journal of medicine.

[140]  Biykem Bozkurt,et al.  2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.

[141]  D. DeMets,et al.  2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.

[142]  J. Banegas,et al.  High prevalence of masked uncontrolled hypertension in people with treated hypertension. , 2014, European heart journal.

[143]  M. Weir.  In the clinic: hypertension. , 2014, Annals of internal medicine.

[144]  M. Ezekowitz,et al.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. , 2014, Circulation.

[145]  G. Parati,et al.  Effects of blood pressure lowering on outcome incidence in hypertension: 2. Effects at different baseline and achieved blood pressure levels – overview and meta-analyses of randomized trials , 2014, Journal of hypertension.

[146]  G. Parati,et al.  Effects of blood pressure lowering on outcome incidence in hypertension: 3. Effects in patients at different levels of cardiovascular risk – overview and meta-analyses of randomized trials , 2014, Journal of hypertension.

[147]  K. Kario,et al.  Prognostic impact from clinic, daytime, and night-time systolic blood pressure in nine cohorts of 13 844 patients with hypertension , 2014, Journal of hypertension.

[148]  S. Oparil,et al.  Rates, amounts, and determinants of ambulatory blood pressure monitoring claim reimbursements among Medicare beneficiaries. , 2014, Journal of the American Society of Hypertension : JASH.

[149]  S. Oparil,et al.  The use of ambulatory blood pressure monitoring among Medicare beneficiaries in 2007-2010. , 2014, Journal of the American Society of Hypertension : JASH.

[150]  J. Rumsfeld,et al.  Impact of the 2014 expert panel recommendations for management of high blood pressure on contemporary cardiovascular practice: insights from the NCDR PINNACLE registry. , 2014, Journal of the American College of Cardiology.

[151]  B. Egan,et al.  Hypertension in the United States, 1999 to 2012: Progress Toward Healthy People 2020 Goals , 2014, Circulation.

[152]  R. Minutolo,et al.  Assessment of achieved clinic and ambulatory blood pressure recordings and outcomes during treatment in hypertensive patients with CKD: a multicenter prospective cohort study. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[153]  Tej K. Khalsa,et al.  Standards for the Uniform Reporting of Hypertension in Adults Using Population Survey Data: Recommendations From the World Hypertension League Expert Committee , 2014, Journal of clinical hypertension.

[154]  D. Conen,et al.  Age-Specific Differences Between Conventional and Ambulatory Daytime Blood Pressure Values , 2014, Hypertension.

[155]  E. O’Brien,et al.  Setting Thresholds to Varying Blood Pressure Monitoring Intervals Differentially Affects Risk Estimates Associated With White-Coat and Masked Hypertension in the Population , 2014, Hypertension.

[156]  Kevin L. Thomas,et al.  Check It, Change It: A Community-Based, Multifaceted Intervention to Improve Blood Pressure Control , 2014, Circulation. Cardiovascular quality and outcomes.

[157]  E. Laws,et al.  Acromegaly: an endocrine society clinical practice guideline. , 2014, The Journal of clinical endocrinology and metabolism.

[158]  P. Bath,et al.  Interventions for deliberately altering blood pressure in acute stroke. , 2014, The Cochrane database of systematic reviews.

[159]  Donna K Arnett,et al.  AHA/ACC/HHS strategies to enhance application of clinical practice guidelines in patients with cardiovascular disease and comorbid conditions: from the American Heart Association, American College of Cardiology, and U.S. Department of Health and Human Services. , 2014, Journal of the American College of Cardiology.

[160]  Richard A. Goodman,et al.  AHA/ACC/HHS strategies to enhance application of clinical practice guidelines in patients with cardiovascular disease and comorbid conditions: from the American Heart Association, American College of Cardiology, and US Department of Health and Human Services. , 2014, Circulation.

[161]  R. Eckel,et al.  Pharmacological treatment and therapeutic perspectives of metabolic syndrome , 2014, Reviews in Endocrine and Metabolic Disorders.

[162]  A. Alexandrov,et al.  Intensive blood pressure reduction in acute intracerebral hemorrhage , 2014, Neurology.

[163]  Manuel Gorostidi,et al.  Prevalence of white-coat and masked hypertension in national and international registries , 2014, Hypertension Research.

[164]  J. Bilal,et al.  Meta-analysis of revascularization versus medical therapy for atherosclerotic renal artery stenosis. , 2014, The American journal of cardiology.

[165]  L. Hemkens,et al.  Clinical effectiveness of stress-reduction techniques in patients with hypertension: systematic review and meta-analysis , 2014, Journal of hypertension.

[166]  M. Bots,et al.  Do subclinical vascular abnormalities precede impaired physical ability and ADL disability? , 2014, Experimental Gerontology.

[167]  R. Prentice,et al.  Potassium Intake and Risk of Stroke in Women With Hypertension and Nonhypertension in the Women’s Health Initiative , 2014, Stroke.

[168]  M. M. Joosten,et al.  Urinary Potassium Excretion and Risk of Developing Hypertension: The Prevention of Renal and Vascular End-Stage Disease Study , 2014, Hypertension.

[169]  S. Laurent,et al.  Dose-Dependent Arterial Destiffening and Inward Remodeling After Olmesartan in Hypertensives With Metabolic Syndrome , 2014, HYPERTENSION.

[170]  V. Gudnason,et al.  Pulse Pressure Relation to Aortic and Left Ventricular Structure in the Age, Gene/Environment Susceptibility (AGES)-Reykjavik Study , 2014, Hypertension.

[171]  Jeffrey L. Anderson,et al.  The Evolution and Future of ACC/AHA Clinical Practice Guidelines: A 30-Year Journey A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2014, Circulation.

[172]  S. Blair,et al.  Effects of cardiorespiratory fitness on blood pressure trajectory with aging in a cohort of healthy men. , 2014, Journal of the American College of Cardiology.

[173]  R. Sacco,et al.  Population Attributable Risks of Hypertension and Diabetes for Cardiovascular Disease and Stroke in the Northern Manhattan Study , 2014, Journal of the American Heart Association.

[174]  Andrew W. Correia,et al.  Temporal Trends in the Population Attributable Risk for Cardiovascular Disease: The Atherosclerosis Risk in Communities Study , 2014, Circulation.

[175]  K. Reynolds,et al.  Effects of low-carbohydrate and low-fat diets: a randomized trial. , 2014, Annals of internal medicine.

[176]  P. Dong,et al.  Brachial Pulse Pressure and Cardiovascular or All‐Cause Mortality in the General Population: A Meta‐Analysis of Prospective Observational Studies , 2014, Journal of clinical hypertension.

[177]  P. Okin,et al.  Regression of electrocardiographic left ventricular hypertrophy or strain is associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patients independent of blood pressure reduction - A LIFE review. , 2014, Journal of Electrocardiology.

[178]  E. Soliman,et al.  Electrocardiographic left ventricular hypertrophy and the risk of adverse cardiovascular events: a critical appraisal. , 2014, Journal of electrocardiology.

[179]  Emma P Bray,et al.  Effect of self-monitoring and medication self-titration on systolic blood pressure in hypertensive patients at high risk of cardiovascular disease: the TASMIN-SR randomized clinical trial. , 2014, JAMA.

[180]  Gang Liu,et al.  Effects of tea intake on blood pressure: a meta-analysis of randomised controlled trials , 2014, British Journal of Nutrition.

[181]  M. Woodward,et al.  Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data , 2014, The Lancet.

[182]  E. Vittinghoff,et al.  Intensive Blood Pressure Control, Falls, and Fractures in Patients with Type 2 Diabetes: The ACCORD Trial , 2014, Journal of General Internal Medicine.

[183]  S. Yusuf,et al.  Association of urinary sodium and potassium excretion with blood pressure. , 2014, The New England journal of medicine.

[184]  Majid Ezzati,et al.  Global sodium consumption and death from cardiovascular causes. , 2014, The New England journal of medicine.

[185]  I. Piña,et al.  Status of Cardiovascular Disease and Stroke in Hispanics/Latinos in the United States: A Science Advisory From the American Heart Association , 2014, Circulation.

[186]  Laura A. Tuttle,et al.  Reproducibility of masked hypertension among adults 30 years or older , 2014, Blood pressure monitoring.

[187]  E. Muxfeldt,et al.  Prevalence and associated factors of obstructive sleep apnea in patients with resistant hypertension. , 2014, American journal of hypertension.

[188]  S. Saydah,et al.  Trends in cardiovascular disease risk factors by obesity level in adults in the United States, NHANES 1999‐2010 , 2014, Obesity.

[189]  P. Levy,et al.  Impact of initial blood pressure on antihypertensive response in patients with acute hypertension. , 2014, The American journal of emergency medicine.

[190]  D. Lackland,et al.  Lowering of Blood Pressure for Recurrent Stroke Prevention , 2014, Stroke.

[191]  D. Strauss,et al.  The Role of ECG in the Diagnosis of Left Ventricular Hypertrophy , 2014, Current cardiology reviews.

[192]  Yan-lu Xu,et al.  Effect of aldosterone antagonists on blood pressure in patients with resistant hypertension: a meta-analysis , 2014, Journal of Human Hypertension.

[193]  B. Davis,et al.  Characteristics and Long-Term Follow-Up of Participants with Peripheral Arterial Disease During ALLHAT , 2014, Journal of General Internal Medicine.

[194]  The pharmacological and surgical management of adults with obesity. , 2014, The Journal of family practice.

[195]  J. Varon,et al.  The Management of Acute Hypertension in Patients With Renal Dysfunction: Labetalol or Nicardipine? , 2014, Postgraduate medicine.

[196]  W. Tworetzky,et al.  Left ventricular diastolic function and characteristics in fetal aortic stenosis. , 2014, The American journal of cardiology.

[197]  T. Wadden,et al.  Reprint: 2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk. , 2014, Journal of the American Pharmacists Association : JAPhA.

[198]  David W. Baker,et al.  A Technology-Based Quality Innovation to Identify Undiagnosed Hypertension Among Active Primary Care Patients , 2014, The Annals of Family Medicine.

[199]  Anilkrishna B. Thota,et al.  Team-based care and improved blood pressure control: a community guide systematic review. , 2014, American journal of preventive medicine.

[200]  Jennifer G. Robinson,et al.  2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2014, Circulation.

[201]  Janusz Wnek,et al.  2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.

[202]  Robert F Kushner,et al.  2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. , 2014, Journal of the American College of Cardiology.

[203]  Jennifer G. Robinson,et al.  2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.

[204]  Jennifer G. Robinson,et al.  2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2014, Circulation.

[205]  Xiao-peng Hu,et al.  Effects of tacrolimus and cyclosporine treatment on metabolic syndrome and cardiovascular risk factors after renal transplantation: a meta‐analysis , 2014, Chinese medical journal.

[206]  P. Whelton.  Sodium, Potassium, Blood Pressure, and Cardiovascular Disease in Humans , 2014, Current Hypertension Reports.

[207]  Walter T Ambrosius,et al.  The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: The Systolic Blood Pressure Intervention Trial (SPRINT) , 2014, Clinical trials.

[208]  G. Fonarow,et al.  ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines. , 2014, Circulation.

[209]  W. Young,et al.  Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. , 2014, The Journal of clinical endocrinology and metabolism.

[210]  L. D’elia,et al.  Potassium-rich diet and risk of stroke: updated meta-analysis. , 2014, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[211]  N. Schneiderman,et al.  Prevalence of hypertension, awareness, treatment, and control in the Hispanic Community Health Study/Study of Latinos. , 2014, American journal of hypertension.

[212]  Brian A Ference,et al.  Clinical Effect of Naturally Random Allocation to Lower Systolic Blood Pressure Beginning Before the Development of Hypertension , 2014, Hypertension.

[213]  Harry Hemingway,et al.  Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people , 2014, The Lancet.

[214]  Ying Peng,et al.  Effects of Early Blood Pressure Lowering on Early and Long-Term Outcomes after Acute Stroke: An Updated Meta-Analysis , 2014, PloS one.

[215]  S. Tobe,et al.  β-Blockers in hypertension: studies and meta-analyses over the years. , 2014, The Canadian journal of cardiology.

[216]  Anne W. Taylor,et al.  Predictors of sexual dysfunction incidence and remission in men. , 2014, The journal of sexual medicine.

[217]  S. Oparil,et al.  Incident ESRD and treatment-resistant hypertension: the reasons for geographic and racial differences in stroke (REGARDS) study. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[218]  S. Daniels,et al.  Update: Ambulatory Blood Pressure Monitoring in Children and Adolescents A Scientific Statement From the American Heart Association , 2014, Hypertension.

[219]  C. Anderson,et al.  Control of Blood Pressure in Hypertensive Neurological Emergencies , 2014, Current Hypertension Reports.

[220]  A. Ahmadvand,et al.  Self-monitoring of blood pressure for improving adherence to antihypertensive medicines and blood pressure control: a randomized controlled trial. , 2014, American journal of hypertension.

[221]  Deepak L. Bhatt,et al.  Refining calcium test for diagnosis of medullary thyroid cancer: cutoffs, procedures and safety , 2014, The New England journal of medicine.

[222]  S. Oparil,et al.  Trends in Hypertension Prevalence, Awareness, Treatment, and Control Among US Adults 80 Years and Older, 1988–2010 , 2014, Journal of clinical hypertension.

[223]  Yuli Huang,et al.  Prehypertension and the risk of stroke , 2014, Neurology.

[224]  T. Okamura,et al.  Vegetarian diets and blood pressure: a meta-analysis. , 2014, JAMA internal medicine.

[225]  J. Mill,et al.  High potassium intake blunts the effect of elevated sodium intake on blood pressure levels. , 2014, Journal of the American Society of Hypertension : JASH.

[226]  A. Mebazaa,et al.  Clevidipine in acute heart failure: Results of the A Study of Blood Pressure Control in Acute Heart Failure-A Pilot Study (PRONTO). , 2014, American heart journal.

[227]  Jackson T. Wright,et al.  Evidence Supporting a Systolic Blood Pressure Goal of Less Than 150 mm Hg in Patients Aged 60 Years or Older: The Minority View , 2014, Annals of Internal Medicine.

[228]  M. Tinetti,et al.  Antihypertensive medications and serious fall injuries in a nationally representative sample of older adults. , 2014, JAMA internal medicine.

[229]  Frank L J Visseren,et al.  Personalized cardiovascular disease prevention by applying individualized prediction of treatment effects. , 2014, European heart journal.

[230]  Teemu J Niiranen,et al.  Prognosis of White-Coat and Masked Hypertension: International Database of Home Blood Pressure in Relation to Cardiovascular Outcome , 2014, Hypertension.

[231]  Willie Lawrence,et al.  An effective approach to high blood pressure control: a science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention , 2013, Hypertension.

[232]  M. Burnier,et al.  Improving Blood Pressure Control Through Pharmacist Interventions: A Meta‐Analysis of Randomized Controlled Trials , 2014, Journal of the American Heart Association.

[233]  Jbs Board.  Joint British Societies’ consensus recommendations for the prevention of cardiovascular disease (JBS3) , 2014, Heart.

[234]  F. Paccaud,et al.  Epidemiology of Masked and White-Coat Hypertension: The Family-Based SKIPOGH Study , 2014, PloS one.

[235]  A. Shah,et al.  Alterations in Cardiac Structure and Function in Hypertension , 2014, Current Hypertension Reports.

[236]  C. Horikawa,et al.  Meta-analysis of the quantitative relation between pulse pressure and mean arterial pressure and cardiovascular risk in patients with diabetes mellitus. , 2014, The American journal of cardiology.

[237]  C. Lewis,et al.  Framingham score and LV mass predict events in young adults: CARDIA study. , 2014, International journal of cardiology.

[238]  Meta-analyses Using Individual Participant Data From Cardiovascular Cohort Studies in Japan: Current Status and Future Directions , 2014 .

[239]  J. Cutler,et al.  Outcomes of Combined Cardiovascular Risk Factor Management Strategies in Type 2 Diabetes: The ACCORD Randomized Trial , 2014, Diabetes Care.

[240]  N. Smart,et al.  Isometric exercise training for blood pressure management: a systematic review and meta-analysis. , 2014, Mayo Clinic proceedings.

[241]  Michael E. Miller,et al.  Cognitive function and brain structure in persons with type 2 diabetes mellitus after intensive lowering of blood pressure and lipid levels: a randomized clinical trial. , 2014, JAMA internal medicine.

[242]  L. Køber,et al.  Association of β-blocker therapy with risks of adverse cardiovascular events and deaths in patients with ischemic heart disease undergoing noncardiac surgery: a Danish nationwide cohort study. , 2014, JAMA internal medicine.

[243]  Graham A Colditz,et al.  The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012. , 2014, JAMA surgery.

[244]  Ralph B D'Agostino,et al.  Stenting and medical therapy for atherosclerotic renal-artery stenosis. , 2014, The New England journal of medicine.

[245]  S. Oparil,et al.  Refractory Hypertension: Determination of Prevalence, Risk Factors, and Comorbidities in a Large, Population-Based Cohort , 2014, Hypertension.

[246]  Jianwen Cai,et al.  The effect of a decision aid intervention on decision making about coronary heart disease risk reduction: secondary analyses of a randomized trial , 2014, BMC Medical Informatics and Decision Making.

[247]  J. Schwartz,et al.  Unmasking masked hypertension: prevalence, clinical implications, diagnosis, correlates and future directions , 2014, Journal of Human Hypertension.

[248]  P. Lai,et al.  First-line beta-blockers versus other antihypertensive medications for chronic type B aortic dissection. , 2014, The Cochrane database of systematic reviews.

[249]  Deepak L. Bhatt,et al.  Variations in coronary artery disease secondary prevention prescriptions among outpatient cardiology practices: insights from the NCDR (National Cardiovascular Data Registry). , 2014, Journal of the American College of Cardiology.

[250]  Juned Siddique,et al.  Blood pressure trajectories in early adulthood and subclinical atherosclerosis in middle age. , 2014, JAMA.

[251]  J. Chen,et al.  Effects of immediate blood pressure reduction on death and major disability in patients with acute ischemic stroke: the CATIS randomized clinical trial. , 2014, JAMA.

[252]  Jackson T. Wright,et al.  2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). , 2014, JAMA.

[253]  P. Whelton,et al.  Health effects of sodium and potassium in humans , 2014, Current opinion in lipidology.

[254]  Dingli Xu,et al.  Association of all-cause and cardiovascular mortality with prehypertension: a meta-analysis. , 2014, American heart journal.

[255]  S. Kelsey,et al.  Cardiovascular and Mortality Risk of Apparent Resistant Hypertension in Women With Suspected Myocardial Ischemia: A Report From the NHLBI‐Sponsored WISE Study , 2014, Journal of the American Heart Association.

[256]  Brett M. Kissela,et al.  Factors Influencing the Decline in Stroke Mortality: A Statement From the American Heart Association/American Stroke Association , 2014, Stroke.

[257]  N. Cook,et al.  Lower Levels of Sodium Intake and Reduced Cardiovascular Risk , 2013, Circulation.

[258]  Janusz Wnek,et al.  2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults , 2013, Circulation.

[259]  P. Glasziou,et al.  General practitioners’ use of absolute risk versus individual risk factors in cardiovascular disease prevention: an experimental study , 2013, BMJ Open.

[260]  R. Shaw,et al.  Effects of Nurse-Managed Protocols in the Outpatient Management of Adults With Chronic Conditions , 2014, Annals of Internal Medicine.

[261]  M. Fornage,et al.  Guidelines for the Primary Prevention of Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association , 2011, Stroke.

[262]  R. Haynes,et al.  Interventions for enhancing medication adherence. , 2008, The Cochrane database of systematic reviews.

[263]  J. Holmes,et al.  Health, United States, 2013 : with special feature on prescription drugs , 2014 .

[264]  E. Denney-Wilson,et al.  Influence of cardiovascular absolute risk assessment on prescribing of antihypertensive and lipid-lowering medications: a cluster randomized controlled trial. , 2014, American heart journal.

[265]  Jianyu Zhang,et al.  Prehypertension and Incidence of ESRD: a systematic review and meta-analysis. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[266]  S. Bangalore,et al.  Prevalence, predictors, and outcomes in treatment-resistant hypertension in patients with coronary disease. , 2014, The American journal of medicine.

[267]  V. Chair,et al.  Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. , 2014, Stroke.

[268]  C. Brisson,et al.  Persistence and Progression of Masked Hypertension: A 5-Year Prospective Study , 2013, International journal of hypertension.

[269]  M. Mosteiro,et al.  Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized clinical trial. , 2013, JAMA.

[270]  Barry I. Freedman,et al.  APOL1 risk variants, race, and progression of chronic kidney disease. , 2013, The New England journal of medicine.

[271]  D. Rodriguez-Leyva,et al.  Potent Antihypertensive Action of Dietary Flaxseed in Hypertensive Patients , 2013, Hypertension.

[272]  Jeremy Sussman,et al.  Using Benefit-Based Tailored Treatment to Improve the Use of Antihypertensive Medications , 2013, Circulation.

[273]  Z. Li,et al.  Association Between Pre-hypertension and Cardiovascular Outcomes: A Systematic Review and Meta-analysis of Prospective Studies , 2013, Current Hypertension Reports.

[274]  P. Peduzzi,et al.  Combined angiotensin inhibition for the treatment of diabetic nephropathy. , 2013, The New England journal of medicine.

[275]  James M. Roberts,et al.  Hypertension in Pregnancy: Executive Summary , 2013 .

[276]  D. de Zeeuw,et al.  Screening for albuminuria with subsequent screening for hypertension and hypercholesterolaemia identifies subjects in whom treatment is warranted to prevent cardiovascular events. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[277]  L. Bortolotto,et al.  Effects of OSA treatment on BP in patients with resistant hypertension: a randomized trial. , 2013, Chest.

[278]  L. Rostaing,et al.  Long‐Term Belatacept Exposure Maintains Efficacy and Safety at 5 Years: Results From the Long‐Term Extension of the BENEFIT Study , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[279]  J. Saavedra,et al.  Effects of exercise on resting blood pressure in obese children: a meta‐analysis of randomized controlled trials , 2013, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[280]  José Agustín Arguedas,et al.  Blood pressure targets for hypertension in people with diabetes mellitus. , 2013, The Cochrane database of systematic reviews.

[281]  R. Hayward,et al.  Providing clinicians with a patient’s 10-year cardiovascular risk improves their statin prescribing: a true experiment using clinical vignettes , 2013, BMC Cardiovascular Disorders.

[282]  G. Habib,et al.  Home Blood Pressure Monitoring in Heart Transplant Recipients: Comparison with Ambulatory Blood Pressure Monitoring , 2013, Transplantation.

[283]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[284]  Youyou Zhao,et al.  Effect of probiotic fermented milk on blood pressure: a meta-analysis of randomised controlled trials. , 2013, The British journal of nutrition.

[285]  Juan Xu,et al.  Impact of baseline prehypertension on cardiovascular events and all-cause mortality in the general population: a meta-analysis of prospective cohort studies. , 2013, International journal of cardiology.

[286]  A. Carriquiry,et al.  Association between Usual Sodium and Potassium Intake and Blood Pressure and Hypertension among U.S. Adults: NHANES 2005–2010 , 2013, PloS one.

[287]  M. Jessup,et al.  The next steps in developing clinical practice guidelines for prevention. , 2013, Circulation.

[288]  M. Lauer,et al.  Refocusing the agenda on cardiovascular guidelines: an announcement from the National Heart, Lung, and Blood Institute. , 2013, Journal of the American College of Cardiology.

[289]  M. Lauer,et al.  Refocusing the agenda on cardiovascular guidelines: an announcement from the National Heart, Lung, and Blood Institute. , 2013, Circulation.

[290]  Jie Wang,et al.  Yoga for Essential Hypertension: A Systematic Review , 2013, PloS one.

[291]  M. Woodward,et al.  Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials , 2013, BMJ.

[292]  V. Burt,et al.  Hypertension among adults in the United States: National Health and Nutrition Examination Survey, 2011-2012. , 2013, NCHS data brief.

[293]  F. Veglio,et al.  Long-term cardio- and cerebrovascular events in patients with primary aldosteronism. , 2013, The Journal of clinical endocrinology and metabolism.

[294]  R. Nishimura,et al.  Systemic Hypertension in Low-Gradient Severe Aortic Stenosis With Preserved Ejection Fraction , 2013, Circulation.

[295]  Zeng-li Zhang,et al.  Effects of high-protein diets on body weight, glycaemic control, blood lipids and blood pressure in type 2 diabetes: meta-analysis of randomised controlled trials. , 2013, The British journal of nutrition.

[296]  T. Urech,et al.  Effects of individual physician-level and practice-level financial incentives on hypertension care: a randomized trial. , 2013, JAMA.

[297]  Naomi S. Bardach,et al.  Effect of pay-for-performance incentives on quality of care in small practices with electronic health records: a randomized trial. , 2013, JAMA.

[298]  S. Oparil,et al.  Prevalence of apparent treatment-resistant hypertension among individuals with CKD. , 2013, Clinical journal of the American Society of Nephrology : CJASN.

[299]  C. Molina,et al.  Impact of blood pressure changes and course on hematoma growth in acute intracerebral hemorrhage , 2013, European journal of neurology.

[300]  J. Gardin,et al.  Longitudinal Determinants of Left Ventricular Mass and Geometry: The Coronary Artery Risk Development in Young Adults (CARDIA) Study , 2013, Circulation. Cardiovascular imaging.

[301]  Mark Woodward,et al.  Comparison of the Sex-Specific Associations Between Systolic Blood Pressure and the Risk of Cardiovascular Disease: A Systematic Review and Meta-analysis of 124 Cohort Studies, Including 1.2 Million Individuals , 2013, Stroke.

[302]  Geoffrey A Head,et al.  European Society of Hypertension position paper on ambulatory blood pressure monitoring. , 2013, Journal of hypertension.

[303]  A. Go,et al.  Improved blood pressure control associated with a large-scale hypertension program. , 2013, JAMA.

[304]  M. Martínez-González,et al.  Mediterranean diet for primary prevention of cardiovascular disease. , 2013, The New England journal of medicine.

[305]  R. Conwit,et al.  Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial , 2013, The Lancet.

[306]  K. Uhlig,et al.  Self-Measured Blood Pressure Monitoring in the Management of Hypertension , 2013, Annals of Internal Medicine.

[307]  H. Tighiouart,et al.  Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis , 2013, Canadian Medical Association Journal.

[308]  Dingli Xu,et al.  Prehypertension and incidence of cardiovascular disease: a meta-analysis , 2013, BMC Medicine.

[309]  P. Stevens,et al.  The impact of pay for performance on the control of blood pressure in people with chronic kidney disease stage 3-5. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[310]  K. Costenbader,et al.  The epidemiology of atherosclerotic cardiovascular disease among patients with SLE: a systematic review. , 2013, Seminars in arthritis and rheumatism.

[311]  Jeroen J. Bax,et al.  2007 ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, Blood pressure.

[312]  Mei-xiang Xiang,et al.  Meta-analysis of cohort studies of baseline prehypertension and risk of coronary heart disease. , 2013, The American journal of cardiology.

[313]  Patrick J O'Connor,et al.  Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. , 2013, JAMA.

[314]  K. Kario,et al.  Systolic Blood Pressure After Intravenous Antihypertensive Treatment and Clinical Outcomes in Hyperacute Intracerebral Hemorrhage: The Stroke Acute Management With Urgent Risk-Factor Assessment and Improvement-Intracerebral Hemorrhage Study , 2013, Stroke.

[315]  F. Tubach,et al.  Progression of aortic valve stenosis is associated with bone remodelling and secondary hyperparathyroidism in elderly patients--the COFRASA study. , 2013, European heart journal.

[316]  E. Manias,et al.  Impact of interventions on medication adherence and blood pressure control in patients with essential hypertension: a systematic review by the ISPOR medication adherence and persistence special interest group. , 2013, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[317]  É. Mousseaux,et al.  Arterial stiffness as an imaging biomarker: are all pathways equal? , 2013, HYPERTENSION.

[318]  A. Pessina,et al.  Long-Term Control of Arterial Hypertension and Regression of Left Ventricular Hypertrophy With Treatment of Primary Aldosteronism , 2013, Hypertension.

[319]  G. Mancia,et al.  Long-Term Prognostic Value of White Coat Hypertension: An Insight From Diagnostic Use of Both Ambulatory and Home Blood Pressure Measurements , 2013, Hypertension.

[320]  Pablo Perel,et al.  The Influence of Health Systems on Hypertension Awareness, Treatment, and Control: A Systematic Literature Review , 2013, PLoS medicine.

[321]  Alex J. Sutton,et al.  Evidence Synthesis for Decision Making 2 , 2013, Medical decision making : an international journal of the Society for Medical Decision Making.

[322]  M. Woodward,et al.  Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. , 2013, The New England journal of medicine.

[323]  M. Nelson,et al.  Primary prevention of cardiovascular disease: new guidelines, technologies and therapies , 2013, The Medical journal of Australia.

[324]  Jiguang Wang,et al.  Effects of Intensive Antihypertensive Treatment on Chinese Hypertensive Patients Older Than 70 Years , 2013, Journal of clinical hypertension.

[325]  C. Gluud,et al.  Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients. , 2013, The Cochrane database of systematic reviews.

[326]  A. Sheikh,et al.  Telemonitoring based service redesign for the management of uncontrolled hypertension: multicentre randomised controlled trial , 2013, BMJ.

[327]  G. M. Allan,et al.  Agreement Among Cardiovascular Disease Risk Calculators , 2013, Circulation.

[328]  E. Peterson,et al.  Variability in performance measures for assessment of hypertension control. , 2013, American heart journal.

[329]  Gunther Eysenbach,et al.  Reducing blood pressure with Internet-based interventions: a meta-analysis. , 2013, The Canadian journal of cardiology.

[330]  K. Lavoie,et al.  The evolution of a Canadian Hypertension Education Program recommendation: the impact of resistance training on resting blood pressure in adults as an example. , 2013, The Canadian journal of cardiology.

[331]  Zhaoqing Sun,et al.  Prehypertension Is Not Associated with All-Cause Mortality: A Systematic Review and Meta-Analysis of Prospective Studies , 2013, PloS one.

[332]  W. Henderson,et al.  Association of perioperative β-blockade with mortality and cardiovascular morbidity following major noncardiac surgery. , 2013, JAMA.

[333]  Lee Hooper,et al.  Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses , 2013, BMJ : British Medical Journal.

[334]  P. Elliott,et al.  Effect of lower sodium intake on health: systematic review and meta-analyses , 2013, BMJ : British Medical Journal.

[335]  G. MacGregor,et al.  Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials , 2013, BMJ : British Medical Journal.

[336]  Shalini Santhakumaran,et al.  Preterm Birth and the Metabolic Syndrome in Adult Life: A Systematic Review and Meta-analysis , 2013, Pediatrics.

[337]  Manesh R. Patel,et al.  Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial. , 2013, JAMA.

[338]  Tom Chan,et al.  Audit-based education lowers systolic blood pressure in chronic kidney disease: the Quality Improvement in CKD (QICKD) trial results , 2013, Kidney international.

[339]  J. Varon,et al.  Intravenous nicardipine and labetalol use in hypertensive patients with signs or symptoms suggestive of end-organ damage in the emergency department: a subgroup analysis of the CLUE trial , 2013, BMJ Open.

[340]  Gianfranco Parati,et al.  Clinical usefulness and cost effectiveness of home blood pressure telemonitoring: meta-analysis of randomized controlled studies , 2013, Journal of hypertension.

[341]  J. Buitelaar,et al.  Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents. , 2013, Journal of child psychology and psychiatry, and allied disciplines.

[342]  D. Magid,et al.  A Pharmacist-Led, American Heart Association Heart360 Web-Enabled Home Blood Pressure Monitoring Program , 2013, Circulation. Cardiovascular quality and outcomes.

[343]  M. Wintermark,et al.  Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2013, Stroke.

[344]  V. Garovic,et al.  Preeclampsia and the Future Risk of Hypertension: The Pregnant Evidence , 2013, Current Hypertension Reports.

[345]  E. Roccella,et al.  The Treatment of Hypertension: A Remarkable Success Story , 2013, Journal of clinical hypertension.

[346]  J. Critchley,et al.  A systematic review of fish-oil supplements for the prevention and treatment of hypertension , 2013, European journal of preventive cardiology.

[347]  S. Fan,et al.  Plasma sodium and blood pressure in individuals on haemodialysis , 2013, Journal of Human Hypertension.

[348]  V. Cornelissen,et al.  Exercise Training for Blood Pressure: A Systematic Review and Meta‐analysis , 2013, Journal of the American Heart Association.

[349]  Jane A. Linderbaum,et al.  2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[350]  Harlan M Krumholz,et al.  2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Circulation.

[351]  Deepak L. Bhatt,et al.  ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[352]  Elizabeth Goodman,et al.  Approaches to the prevention and management of childhood obesity: the role of social networks and the use of social media and related electronic technologies: a scientific statement from the American Heart Association. , 2013, Circulation.

[353]  Deepak L. Bhatt,et al.  ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[354]  F. Beuschlein,et al.  Effectiveness of eplerenone or spironolactone treatment in preserving renal function in primary aldosteronism. , 2012, European journal of endocrinology.

[355]  Alan D. Lopez,et al.  A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[356]  B. Astor,et al.  Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans , 2012, Kidney international.

[357]  T. Rice,et al.  Reproducibility of Blood Pressure Responses to Dietary Sodium and Potassium Interventions: The GenSalt Study , 2012, Hypertension.

[358]  D. Simons-Morton,et al.  Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: Summary Report , 2011, Pediatrics.

[359]  B. Davis,et al.  The Glycemic Effects of Antihypertensive Medications , 2013, Current Hypertension Reports.

[360]  G. Bray,et al.  Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. , 2013, The New England journal of medicine.

[361]  S. Bakker,et al.  Intake of total protein, plant protein and animal protein in relation to blood pressure: a meta-analysis of observational and intervention studies , 2013, Journal of Human Hypertension.

[362]  M. Yang,et al.  Immunosuppressant utilization and cardiovascular complications among Chinese patients after kidney transplantation: a systematic review and analysis , 2013, International Urology and Nephrology.

[363]  Sankey V. Williams,et al.  2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Ass , 2012, Journal of the American College of Cardiology.

[364]  Audrey Y. Chu,et al.  Body Mass Index and Risk of Incident Hypertension Over the Life Course: The Johns Hopkins Precursors Study , 2012, Circulation.

[365]  Sankey V. Williams,et al.  2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physi , 2012, Circulation.

[366]  A. Banerjee,et al.  Web-Based Patient-Reported Outcomes in Drug Safety and Risk Management , 2012, Drug Safety.

[367]  E. Antman,et al.  Sodium, Blood Pressure, and Cardiovascular Disease: Further Evidence Supporting the American Heart Association Sodium Reduction Recommendations , 2012, Circulation.

[368]  Nish Chaturvedi,et al.  Cardiorenal end points in a trial of aliskiren for type 2 diabetes. , 2012, The New England journal of medicine.

[369]  David C. Wheeler,et al.  Notice , 2012, Kidney International Supplements.

[370]  苅尾 七臣,et al.  ガイドライン解説 AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease : 2011 update , 2012 .

[371]  P. Erwin,et al.  The effect of coffee consumption on blood pressure and the development of hypertension: a systematic review and meta-analysis , 2012, Journal of hypertension.

[372]  T. Ohkubo,et al.  Long-term risk of BP values above normal for cardiovascular mortality: a 24-year observation of Japanese aged 30 to 92 years , 2012, Journal of hypertension.

[373]  Rafal S. Sobota,et al.  Salt Sensitivity of Blood Pressure Is Associated With Polymorphisms in the Sodium-Bicarbonate Cotransporter , 2012, Hypertension.

[374]  Jean Sanderson,et al.  The Role of Decision Support System (DSS) in Prevention of Cardiovascular Disease: A Systematic Review and Meta-Analysis , 2012, PloS one.

[375]  M. Woodward,et al.  Effects of blood pressure lowering on cardiovascular outcomes in different cardiovascular risk groups among participants with type 2 diabetes. , 2012, Diabetes research and clinical practice.

[376]  P. Glasziou,et al.  Prioritising CVD prevention therapy - absolute risk versus individual risk factors. , 2012, Australian family physician.

[377]  Jiang He,et al.  Dietary protein intake and blood pressure: a meta-analysis of randomized controlled trials. , 2012, American journal of epidemiology.

[378]  Meera Viswanathan,et al.  Closing the quality gap: revisiting the state of the science (vol. 4: medication adherence interventions: comparative effectiveness). , 2012, Evidence report/technology assessment.

[379]  A. Carriquiry,et al.  Sodium and potassium intakes among US adults: NHANES 2003-2008. , 2012, The American journal of clinical nutrition.

[380]  J. Staessen,et al.  Cardiovascular outcomes in the first trial of antihypertensive therapy guided by self-measured home blood pressure , 2012, Hypertension Research.

[381]  R. Majdzadeh,et al.  Quality of health news disseminated in the print media in developing countries: a case study in Iran , 2012, BMC Public Health.

[382]  D. Bluemke,et al.  LV mass assessed by echocardiography and CMR, cardiovascular outcomes, and medical practice. , 2012, JACC. Cardiovascular imaging.

[383]  T. Lehtimäki,et al.  The Cardiovascular Risk in Young Finns Study , 2008 .

[384]  T. Vos,et al.  Which Interventions Offer Best Value for Money in Primary Prevention of Cardiovascular Disease? , 2012, PloS one.

[385]  I. Ilie,et al.  Acute aortic occlusion by massive piling-up of large unstable thoraco-abdominal thrombi attributable to heparin-induced thrombocytopenia. , 2012, Circulation.

[386]  G. Stergiou,et al.  Home versus ambulatory and office blood pressure in predicting target organ damage in hypertension: a systematic review and meta-analysis , 2012, Journal of hypertension.

[387]  T. Cleophas,et al.  Potassium treatment for hypertension in patients with high salt intake: a meta-analysis. , 2012, International journal of clinical pharmacology and therapeutics.

[388]  G. Stergiou,et al.  Diagnostic accuracy of home vs. ambulatory blood pressure monitoring in untreated and treated hypertension , 2012, Hypertension Research.

[389]  E. Staal,et al.  Hypertension in Aortic Stenosis: Implications for Left Ventricular Structure and Cardiovascular Events , 2012, Hypertension.

[390]  K. Eagle,et al.  The United States Registry for Fibromuscular Dysplasia: Results in the First 447 Patients , 2012, Circulation.

[391]  T. Vos,et al.  Improving the cost-effectiveness of cardiovascular disease prevention in Australia: a modelling study , 2012, BMC Public Health.

[392]  Catherine M. Brown,et al.  Hypertension in pregnancy: is it time for a new approach to treatment? , 2012, Journal of hypertension.

[393]  Joseph E Schwartz,et al.  Masked hypertension and prehypertension: diagnostic overlap and interrelationships with left ventricular mass: the Masked Hypertension Study. , 2012, American journal of hypertension.

[394]  N. J. Guzman.  Epidemiology and Management of Hypertension in the Hispanic Population , 2012, American Journal of Cardiovascular Drugs.

[395]  Ferran Barbé,et al.  Association between treated and untreated obstructive sleep apnea and risk of hypertension. , 2012, JAMA.

[396]  L. Appel,et al.  Strategies to Reduce Dietary Sodium Intake , 2012, Current Treatment Options in Cardiovascular Medicine.

[397]  J. Selby,et al.  Improving Blood Pressure Control Through a Clinical Pharmacist Outreach Program in Patients With Diabetes Mellitus in 2 High-Performing Health Systems: The Adherence and Intensification of Medications Cluster Randomized, Controlled Pragmatic Trial , 2012, Circulation.

[398]  A. Thrift,et al.  Organized Blood Pressure Control Programs to Prevent Stroke in Australia: Would They Be Cost-Effective? , 2012, Stroke.

[399]  D. Thom,et al.  Health Coaching to Improve Hypertension Treatment in a Low-Income, Minority Population , 2012, The Annals of Family Medicine.

[400]  Hilary K. Wall,et al.  National Surveillance Definitions for Hypertension Prevalence and Control Among Adults , 2012, Circulation. Cardiovascular quality and outcomes.

[401]  S. Flottorp,et al.  Comparative effectiveness of antihypertensive medication for primary prevention of cardiovascular disease: systematic review and multiple treatments meta-analysis , 2012, BMC Medicine.

[402]  J. Geleijnse,et al.  Cardiovascular risk management of hypertension and hypercholesterolaemia in the Netherlands: from unifactorial to multifactorial approach , 2012, Netherlands Heart Journal.

[403]  J. Olesen,et al.  The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0–1: A nationwide cohort study , 2012, Thrombosis and Haemostasis.

[404]  K. Eagle,et al.  Type-selective benefits of medications in treatment of acute aortic dissection (from the International Registry of Acute Aortic Dissection [IRAD]). , 2012, The American journal of cardiology.

[405]  K. Mukamal.  Understanding the mechanisms that link alcohol and lower risk of coronary heart disease. , 2012, Clinical chemistry.

[406]  W. Cushman,et al.  Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients. , 2012, Kidney international.

[407]  J. Tardif,et al.  Determinants of masked hypertension in hypertensive patients treated in a primary care setting , 2012, Internal medicine journal.

[408]  H. Wallaschofski,et al.  Prevalence of Primary Aldosteronism in Patient’s Cohorts and in Population-based Studies – A Review of the Current Literature , 2011, Hormone and Metabolic Research.

[409]  R. Webb,et al.  New insights into hypertension-associated erectile dysfunction , 2012, Current opinion in nephrology and hypertension.

[410]  Carl Heneghan,et al.  Home measurement of blood pressure and cardiovascular disease: systematic review and meta-analysis of prospective studies , 2012, Journal of hypertension.

[411]  D. Sessler,et al.  Angiotensin Converting Enzyme Inhibitors Are Not Associated with Respiratory Complications or Mortality After Noncardiac Surgery , 2012, Anesthesia and analgesia.

[412]  E. O’Brien,et al.  Significance of White-Coat Hypertension in Older Persons With Isolated Systolic Hypertension: A Meta-Analysis Using the International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes Population , 2012, Hypertension.

[413]  L. Carpenter,et al.  Effect of magnesium supplementation on blood pressure: a meta-analysis , 2012, European Journal of Clinical Nutrition.

[414]  E. Muxfeldt,et al.  Appropriate Time Interval to Repeat Ambulatory Blood Pressure Monitoring in Patients With White-Coat Resistant Hypertension , 2012, Hypertension.

[415]  C. Ding,et al.  Further improvement in quantifying male fetal DNA in maternal plasma. , 2012, Clinical chemistry.

[416]  M. Monuteaux,et al.  Systematic Review and Meta-Analysis of Preterm Birth and Later Systolic Blood Pressure , 2012, Hypertension.

[417]  Avis J. Thomas,et al.  Lifetime risks of cardiovascular disease. , 2012, The New England journal of medicine.

[418]  Stacey L. Sheridan,et al.  Use of global coronary heart disease risk assessment in practice: a cross-sectional survey of a sample of U.S. physicians , 2012, BMC Health Services Research.

[419]  C. Agyemang,et al.  Overcoming barriers to hypertension control in African Americans , 2012, Cleveland Clinic Journal of Medicine.

[420]  J. Saver,et al.  Renin–Angiotensin System Modulators Modestly Reduce Vascular Risk in Persons With Prior Stroke , 2012, Stroke.

[421]  G. Koren,et al.  The Fetal Safety of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers , 2011, Obstetrics and gynecology international.

[422]  S. Yusuf,et al.  Safety and efficacy of low blood pressures among patients with diabetes: subgroup analyses from the ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial). , 2012, Journal of the American College of Cardiology.

[423]  Ethan M Balk,et al.  Self-Measured Blood Pressure Monitoring: Comparative Effectiveness , 2012 .

[424]  Lee Hooper,et al.  Guideline: Potassium intake for adults and children , 2012 .

[425]  F. Messerli,et al.  Drug-induced hypertension: an unappreciated cause of secondary hypertension. , 2012, The American journal of medicine.

[426]  M. Bulsara,et al.  The Fremantle Primary Prevention Study: a multicentre randomised trial of absolute cardiovascular risk reduction. , 2012, The British journal of general practice : the journal of the Royal College of General Practitioners.

[427]  G. Jürgens,et al.  Effects of low-sodium diet vs. high-sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride (Cochrane Review). , 2012, American journal of hypertension.

[428]  P. Hebert,et al.  Nurse-led Disease Management for Hypertension Control in a Diverse Urban Community: a Randomized Trial , 2012, Journal of General Internal Medicine.

[429]  Jerry Q. Cheng,et al.  Association between chlorthalidone treatment of systolic hypertension and long-term survival. , 2011, JAMA.

[430]  Jianwen Cai,et al.  A randomized trial of an intervention to improve use and adherence to effective coronary heart disease prevention strategies , 2011, BMC health services research.

[431]  B. Sherrill,et al.  Single‐Pill vs Free‐Equivalent Combination Therapies for Hypertension: A Meta‐Analysis of Health Care Costs and Adherence , 2011, Journal of clinical hypertension.

[432]  A. Pessina,et al.  Drug-related hypertension and resistance to antihypertensive treatment: a call for action , 2011, Journal of hypertension.

[433]  Mike Kirby,et al.  Guidelines on the management of cardiovascular diseases during pregnancy The Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology ( ESC ) , 2011 .

[434]  John Spertus,et al.  AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. , 2011, Circulation.

[435]  Terence Dwyer,et al.  Childhood adiposity, adult adiposity, and cardiovascular risk factors. , 2011, The New England journal of medicine.

[436]  Christoph U. Lehmann,et al.  ADHD: Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents , 2011, Pediatrics.

[437]  T. Douglas Bradley,et al.  Obstructive Sleep Apnea: The Most Common Secondary Cause of Hypertension Associated With Resistant Hypertension , 2011, Hypertension.

[438]  B. Davis,et al.  Long-Term Follow-Up of Participants With Heart Failure in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) , 2011, Circulation.

[439]  S. Yusuf,et al.  Blood Pressure Targets Recommended by Guidelines and Incidence of Cardiovascular and Renal Events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET) , 2011, Circulation.

[440]  J. Sterne,et al.  The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials , 2011, BMJ : British Medical Journal.

[441]  B. Ovbiagele,et al.  Presence of baseline prehypertension and risk of incident stroke , 2011, Neurology.

[442]  F. Rodríguez‐Artalejo,et al.  The effect of coffee on blood pressure and cardiovascular disease in hypertensive individuals: a systematic review and meta-analysis. , 2011, The American journal of clinical nutrition.

[443]  B. Egan,et al.  Progression Is Accelerated From Prehypertension to Hypertension in Blacks , 2011, Hypertension.

[444]  E. DeLong,et al.  ACCF/AHA Methodology for the Development of Quality Measures for Cardiovascular Technology: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures , 2011, Circulation.

[445]  関 厚二朗,et al.  Tissue plasminogen activator for acute ischemic stroke , 2011 .

[446]  M. Briel,et al.  Meta-analysis comparing Mediterranean to low-fat diets for modification of cardiovascular risk factors. , 2011, The American journal of medicine.

[447]  G. Bakris,et al.  Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial. , 2011, Journal of the American College of Cardiology.

[448]  Daniel W. Jones,et al.  Effect of dietary protein supplementation on blood pressure: a randomized, controlled trial. , 2011, Circulation.

[449]  Merlin C. Thomas,et al.  An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function. , 2011, Kidney international.

[450]  D. Leonard,et al.  Improving Adherence With Amlodipine/Atorvastatin Therapy: IMPACT Study , 2011, Journal of clinical hypertension.

[451]  Stephen D. Persell,et al.  ACCF/AHA/AMA-PCPI 2011 performance measures for adults with coronary artery disease and hypertension: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consortium for Performance Impr , 2011, Circulation.

[452]  Valerie Smith,et al.  Home blood pressure management and improved blood pressure control: results from a randomized controlled trial. , 2011, Archives of internal medicine.

[453]  M. Maurer,et al.  Heart Failure with Preserved Ejection Fraction: Persistent Diagnosis, Therapeutic Enigma , 2011, Current cardiovascular risk reports.

[454]  A. Nabhan,et al.  Tight control of mild-moderate pre-existing or non-proteinuric gestational hypertension. , 2011, The Cochrane database of systematic reviews.

[455]  G. Mancia,et al.  Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73 913 patients , 2011, Journal of hypertension.

[456]  L. Laghi,et al.  Blood pressure lowering effect of lactotripeptides assumed as functional foods: a meta-analysis of current available clinical trials , 2011, Journal of Human Hypertension.

[457]  J. Varon,et al.  CLUE: a randomized comparative effectiveness trial of IV nicardipine versus labetalol use in the emergency department , 2011, Critical care.

[458]  R. Woolson,et al.  Measuring Blood Pressure for Decision Making and Quality Reporting: Where and How Many Measures? , 2011, Annals of Internal Medicine.

[459]  K. Bibbins-Domingo,et al.  Systolic blood pressure and incident heart failure in the elderly. The Cardiovascular Health Study and the Health, Ageing and Body Composition Study , 2011, Heart.

[460]  P. Stewart,et al.  Inherited forms of mineralocorticoid hypertension , 2011, Current opinion in endocrinology, diabetes, and obesity.

[461]  J. Whitworth,et al.  How do glucocorticoids cause hypertension: role of nitric oxide deficiency, oxidative stress, and eicosanoids. , 2011, Endocrinology and metabolism clinics of North America.

[462]  A. Kessels,et al.  Telecare is a valuable tool for hypertension management, a systematic review and meta-analysis , 2011, Blood pressure monitoring.

[463]  Stephen D. Persell.  Prevalence of Resistant Hypertension in the United States, 2003–2008 , 2011, Hypertension.

[464]  Mahboob Rahman,et al.  Limitations of Analyses Based on Achieved Blood Pressure: Lessons From the African American Study of Kidney Disease and Hypertension Trial , 2011, Hypertension.

[465]  G. Howard,et al.  Ethnic Differences in Hypertension Incidence Among Middle-Aged and Older Adults: The Multi-Ethnic Study of Atherosclerosis , 2011, Hypertension.

[466]  Alan S. Brown,et al.  ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. , 2011, Circulation.

[467]  David M. Eddy,et al.  Individualized Guidelines: The Potential for Increasing Quality and Reducing Costs , 2011, Annals of Internal Medicine.

[468]  E. Ford.  Trends in Mortality From All Causes and Cardiovascular Disease Among Hypertensive and Nonhypertensive Adults in the United States , 2011, Circulation.

[469]  Amy Earley,et al.  Systematic Review: Blood Pressure Target in Chronic Kidney Disease and Proteinuria as an Effect Modifier , 2011, Annals of Internal Medicine.

[470]  Marie T. Brown,et al.  Medication adherence: WHO cares? , 2011, Mayo Clinic proceedings.

[471]  L. Balluz,et al.  Serum α-carotene concentrations and risk of death among US Adults: the Third National Health and Nutrition Examination Survey Follow-up Study. , 2011, Archives of internal medicine.

[472]  Jennifer Dunn Geier,et al.  Credible knowledge: A pilot evaluation of a modified GRADE method using parent-implemented interventions for children with autism , 2011, BMC health services research.

[473]  Faha,et al.  Aha Guideline Effectiveness-based Guidelines for the Prevention of Cardiovascular Disease in Women—2011 Update a Guideline from the American Heart Association Executive Writing Committee Expert Panel Members Cvd Risk Assessment Table 1. Class Iii Interventions (not Useful/effective and May Be Harmfu , 2022 .

[474]  François Gueyffier,et al.  The Global Risk Approach Should Be Better Applied in French Hypertensive Patients: A Comparison between Simulation and Observation Studies , 2011, PloS one.

[475]  K. Reynolds,et al.  Antihypertensive Treatment and Secondary Prevention of Cardiovascular Disease Events Among Persons Without Hypertension: A Meta-Analysis , 2012 .

[476]  G. Bakris,et al.  Combination Therapy in Hypertension , 2011, Journal of clinical hypertension.

[477]  Ihab Hajjar,et al.  Hypertension, Orthostatic Hypotension, and the Risk of Falls in a Community‐Dwelling Elderly Population: The Maintenance of Balance, Independent Living, Intellect, and Zest in the Elderly of Boston Study , 2011, Journal of the American Geriatrics Society.

[478]  M. Caulfield,et al.  Impact of amlodipine-based therapy among older and younger patients in the Anglo-Scandinavian Cardiac Outcomes Trial−Blood Pressure Lowering Arm (ASCOT-BPLA) , 2011, Journal of hypertension.

[479]  F. Cappuccio,et al.  Potassium intake, stroke, and cardiovascular disease a meta-analysis of prospective studies. , 2011, Journal of the American College of Cardiology.

[480]  D. Jatužis,et al.  The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial , 2011, The Lancet.

[481]  Gretchen A. Stevens,et al.  National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5·4 million participants , 2011, The Lancet.

[482]  John E Jones,et al.  Genetics of Salt-Sensitive Hypertension , 2011, Current hypertension reports.

[483]  S. Yusuf,et al.  Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies , 2011, The Lancet Neurology.

[484]  M. Woodward,et al.  The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials , 2011, Journal of hypertension.

[485]  J. Gardin,et al.  Erectile Dysfunction: A Disease Marker for Cardiovascular Disease , 2011, Cardiology in review.

[486]  P. Heuschmann,et al.  Antihypertensive treatment after first stroke in primary care: results from the General Practitioner Research Database , 2011, Journal of hypertension.

[487]  R. Light,et al.  Role of Home Blood Pressure Monitoring in Overcoming Therapeutic Inertia and Improving Hypertension Control: A Systematic Review and Meta-Analysis , 2011, Hypertension.

[488]  F. Cappuccio,et al.  POTASSIUM INTAKE, STROKE, AND CARDIOVASCULAR DISEASE: A META-ANALYSIS OF PROSPECTIVE STUDIES , 2011 .

[489]  F. Cuccurullo,et al.  Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: an updated meta analysis. , 2011, American journal of hypertension.

[490]  S. Greenfield,et al.  Clinical practice guidelines we can trust , 2011 .

[491]  Laura A. Levit,et al.  Finding what works in health care : standards for systematic reviews , 2011 .

[492]  Zahi A Fayad,et al.  2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2010, Circulation.

[493]  Zahi A Fayad,et al.  2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2010, Journal of the American College of Cardiology.

[494]  B. Nordestgaard,et al.  Common clinical practice versus new PRIM score in predicting coronary heart disease risk. , 2010, Atherosclerosis.

[495]  M. Woodward,et al.  Effects of a fixed combination of perindopril and indapamide in patients with type 2 diabetes and chronic kidney disease. , 2010, European heart journal.

[496]  A. Viera,et al.  Reproducibility of masked hypertension in adults with untreated borderline office blood pressure: comparison of ambulatory and home monitoring. , 2010, American journal of hypertension.

[497]  T. Saruta,et al.  Impact of renal function on cardiovascular events in elderly hypertensive patients treated with efonidipine , 2010, Hypertension Research.

[498]  K. Asayama,et al.  Usefulness of assessing masked and white-coat hypertension by ambulatory blood pressure monitoring for determining prevalent risk of chronic kidney disease: the Ohasama study , 2010, Hypertension Research.

[499]  S. Nesbitt,et al.  Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statement. , 2010, Hypertension.

[500]  L. Colantonio,et al.  ' s response to reviews Title : Estimation of the burden of cardiovascular disease attributable to modifiable risk factors and cost-effectiveness analysis of preventative interventions to reduce this burden in Argentina , 2010 .

[501]  G. Liguori,et al.  Persistent Increase of Prevalence of Metabolic Syndrome Among U.S. Adults: NHANES III to NHANES 1999–2006 , 2010, Diabetes Care.

[502]  A. Wallace,et al.  Association of the Pattern of Use of Perioperative &bgr;-Blockade and Postoperative Mortality , 2010, Anesthesiology.

[503]  P. Lloberes,et al.  Continuous positive airway pressure treatment in sleep apnea patients with resistant hypertension: a randomized, controlled trial , 2010, Journal of hypertension.

[504]  I. Kantola,et al.  The choice of home blood pressure result reporting method is essential: Results mailed to physicians did not improve hypertension control compared with ordinary office-based blood pressure treatment , 2010, Blood pressure.

[505]  Keith C. Norris,et al.  Intensive blood-pressure control in hypertensive chronic kidney disease. , 2010, The New England journal of medicine.

[506]  A. Worsley,et al.  Influence of dietary modifications on the blood pressure response to antihypertensive medication , 2010, British Journal of Nutrition.

[507]  Rod S Taylor,et al.  Nurse led interventions to improve control of blood pressure in people with hypertension: systematic review and meta-analysis , 2010, BMJ : British Medical Journal.

[508]  J. Orloff,et al.  Evaluation of compliance and health care utilization in patients treated with single pill vs. free combination antihypertensives , 2010, Current medical research and opinion.

[509]  Muke Zhou,et al.  Calcium channel blockers versus other classes of drugs for hypertension. , 2010, The Cochrane database of systematic reviews.

[510]  Stacey L. Sheridan,et al.  Global risk of coronary heart disease: assessment and application. , 2010, American family physician.

[511]  B. Brenner,et al.  Comparison of different measures of urinary protein excretion for prediction of renal events. , 2010, Journal of the American Society of Nephrology : JASN.

[512]  C. Bulpitt,et al.  Effects of antihypertensive treatment after acute stroke in the Continue Or Stop post-Stroke Antihypertensives Collaborative Study (COSSACS): a prospective, randomised, open, blinded-endpoint trial , 2010, The Lancet Neurology.

[513]  D. Mozaffarian,et al.  Interventions to Promote Physical Activity and Dietary Lifestyle Changes for Cardiovascular Risk Factor Reduction in Adults A Scientific Statement From the American Heart Association Endorsed by the Preventive Cardiovascular Nurses Association and the Society of Behavioral Medicine , 2010 .

[514]  J. Kopple,et al.  The effect of nutrition on blood pressure. , 2010, Annual review of nutrition.

[515]  N. Stocks,et al.  Does chocolate reduce blood pressure? A meta-analysis , 2010, BMC medicine.

[516]  M. Woodward,et al.  Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis , 2010, The Lancet.

[517]  L. Trinquart,et al.  Efficacy of Revascularization For Renal Artery Stenosis Caused by Fibromuscular Dysplasia: A Systematic Review and Meta-Analysis , 2010, Hypertension.

[518]  Devin M Mann,et al.  Comparison of the Framingham Heart Study Hypertension Model With Blood Pressure Alone in the Prediction of Risk of Hypertension: The Multi-Ethnic Study of Atherosclerosis , 2010, Hypertension.

[519]  Li-sheng Liu,et al.  Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trial , 2010, Journal of hypertension.

[520]  Ian J. Brown,et al.  Dietary sources of sodium in China, Japan, the United Kingdom, and the United States, women and men aged 40 to 59 years: the INTERMAP study. , 2010, Journal of the American Dietetic Association.

[521]  M. Woodward,et al.  Impact of Blood Pressure Lowering on Cardiovascular Outcomes in Normal Weight, Overweight, and Obese Individuals: The Perindopril Protection Against Recurrent Stroke Study Trial , 2010, Hypertension.

[522]  Kevin A Peterson,et al.  Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus , 2011 .

[523]  T. Brennan,et al.  Disease management to promote blood pressure control among African Americans. , 2010, Population health management.

[524]  R. Woolson,et al.  Does dark chocolate have a role in the prevention and management of hypertension?: commentary on the evidence. , 2010, Hypertension.

[525]  Geoffrey A Head,et al.  Definition of ambulatory blood pressure targets for diagnosis and treatment of hypertension in relation to clinic blood pressure: prospective cohort study , 2010, BMJ : British Medical Journal.

[526]  David M. Williams,et al.  2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the diagnosis and management of patients with thoracic aortic disease. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, Ame , 2010, Journal of the American College of Cardiology.

[527]  K. Ferdinand.  Management of High Blood Pressure in African Americans and the 2010 ISHIB Consensus Statement: Meeting an Unmet Need , 2010, Journal of clinical hypertension.

[528]  G. Grassi,et al.  European Society of Hypertension Working Group on Obesity Antihypertensive effects of weight loss: myth or reality? , 2010, Journal of hypertension.

[529]  J. Montserrat,et al.  Long-term effect of continuous positive airway pressure in hypertensive patients with sleep apnea. , 2010, American journal of respiratory and critical care medicine.

[530]  M. Godwin,et al.  A primary care pragmatic cluster randomized trial of the use of home blood pressure monitoring on blood pressure levels in hypertensive patients with above target blood pressure. , 2010, Family practice.

[531]  A. Klatsky.  Alcohol and cardiovascular mortality: common sense and scientific truth. , 2010, Journal of the American College of Cardiology.

[532]  Sowmya R. Rao,et al.  Alcohol consumption and cardiovascular mortality among U.S. adults, 1987 to 2002. , 2010, Journal of the American College of Cardiology.

[533]  Tom Fahey,et al.  Interventions used to improve control of blood pressure in patients with hypertension. , 2010, The Cochrane database of systematic reviews.

[534]  Jackson T. Wright,et al.  ORIGINAL INVESTIGATIONS Pathogenesis and Treatment of Kidney Disease Hypertension Awareness, Treatment, and Control in Adults With CKD: Results From the Chronic Renal Insufficiency Cohort (CRIC) Study , 2010 .

[535]  A. Cass,et al.  Cardiovascular risk perception and evidence–practice gaps in Australian general practice (the AusHEART study) , 2010, The Medical journal of Australia.

[536]  A. Jahangir,et al.  Use of herbal products and potential interactions in patients with cardiovascular diseases. , 2010, Journal of the American College of Cardiology.

[537]  Anthony J Viera,et al.  The effect of giving global coronary risk information to adults: a systematic review. , 2010, Archives of internal medicine.

[538]  A. Qureshi.  Antihypertensive treatment of acute cerebral hemorrhage* , 2010, Critical care medicine.

[539]  N. Poulter,et al.  Compliance, Safety, and Effectiveness of Fixed-Dose Combinations of Antihypertensive Agents: A Meta-Analysis , 2010, Hypertension.

[540]  P. Lin,et al.  Effects of the DASH diet alone and in combination with exercise and weight loss on blood pressure and cardiovascular biomarkers in men and women with high blood pressure: the ENCORE study. , 2010, Archives of internal medicine.

[541]  S. Denardo,et al.  Outcomes Among Hypertensive Patients With Concomitant Peripheral and Coronary Artery Disease: Findings From the INternational VErapamil-SR/Trandolapril STudy , 2010, Hypertension.

[542]  Christine L. Taylor,et al.  Strategies to Reduce Sodium Intake in the United States , 2010 .

[543]  B. Davis,et al.  Atrial fibrillation at baseline and during follow-up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial). , 2009, Journal of the American College of Cardiology.

[544]  Martha B. Adams,et al.  Two Self-management Interventions to Improve Hypertension Control , 2009, Annals of Internal Medicine.

[545]  P. Lin,et al.  Hypertension Improvement Project: Randomized Trial of Quality Improvement for Physicians and Lifestyle Modification for Patients , 2009, Hypertension.

[546]  H. Pavenstädt,et al.  Blood pressure, antihypertensive treatment, and graft survival in kidney transplant patients , 2009, Transplant international : official journal of the European Society for Organ Transplantation.

[547]  Li-sheng Liu,et al.  Blood pressure reduction for the secondary prevention of stroke: a Chinese trial and a systematic review of the literature , 2009, Hypertension Research.

[548]  L. Thijs,et al.  Regression of Left Ventricular Mass by Antihypertensive Treatment: A Meta-Analysis of Randomized Comparative Studies , 2009, Hypertension.

[549]  Shimin Zheng,et al.  The potency of team-based care interventions for hypertension: a meta-analysis. , 2009, Archives of internal medicine.

[550]  S. Lakhan,et al.  Blood pressure lowering treatment for preventing stroke recurrence: a systematic review and meta-analysis , 2009, International archives of medicine.

[551]  R. Peters,et al.  A systematic review of selective and non-selective beta blockers for prevention of vascular events in patients with acute coronary syndrome or heart failure. , 2009, The Netherlands journal of medicine.

[552]  H. Rothnie,et al.  Long-Term Weight Loss From Lifestyle Intervention Benefits Blood Pressure?: A Systematic Review , 2009, Hypertension.

[553]  G. Mancia,et al.  Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. , 2009, Journal of hypertension.

[554]  A. Cass,et al.  Gaps in cardiovascular disease risk management in Australian general practice , 2009, The Medical journal of Australia.

[555]  S. Oparil,et al.  Effects of Dietary Sodium Reduction on Blood Pressure in Subjects With Resistant Hypertension: Results From a Randomized Trial , 2009, Hypertension.

[556]  J. Staessen,et al.  Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial , 2009, The Lancet.

[557]  W. Peacock,et al.  Intravenous therapy for hypertensive emergencies, part 2. , 2009, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[558]  W. Peacock,et al.  Intravenous therapy for hypertensive emergencies, part 1. , 2009, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[559]  G. Mancia,et al.  Long-Term Risk of Sustained Hypertension in White-Coat or Masked Hypertension , 2009, Hypertension.

[560]  M. Stampfer,et al.  Diet and lifestyle risk factors associated with incident hypertension in women. , 2009, JAMA.

[561]  J. Ioannidis,et al.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration , 2009, BMJ : British Medical Journal.

[562]  A. Webster,et al.  Antihypertensive treatment for kidney transplant recipients. , 2024, The Cochrane database of systematic reviews.

[563]  M. Kaste,et al.  Relationship of Blood Pressure, Antihypertensive Therapy, and Outcome in Ischemic Stroke Treated With Intravenous Thrombolysis: Retrospective Analysis From Safe Implementation of Thrombolysis in Stroke-International Stroke Thrombolysis Register (SITS-ISTR) , 2009, Stroke.

[564]  M. Pencina,et al.  Longitudinal Tracking of Left Ventricular Mass Over the Adult Life Course: Clinical Correlates of Short- and Long-Term Change in the Framingham Offspring Study , 2009, Circulation.

[565]  A. Cohen-Solal,et al.  Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure). , 2009, Journal of the American College of Cardiology.

[566]  N J Wald,et al.  Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies , 2009, BMJ : British Medical Journal.

[567]  B. Davis,et al.  ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analyses. , 2009, Archives of internal medicine.

[568]  A. Anstey.  Home UVB phototherapy for psoriasis , 2009, BMJ : British Medical Journal.

[569]  P. Muntner,et al.  Barriers to and determinants of medication adherence in hypertension management: perspective of the cohort study of medication adherence among older adults. , 2009, The Medical clinics of North America.

[570]  G. Lip,et al.  Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study. , 2009, European heart journal.

[571]  R. Fagard,et al.  Influence of exercise at lower and higher intensity on blood pressure and cardiovascular risk factors at older age , 2009, Journal of hypertension.

[572]  D. Mozaffarian,et al.  The Preventable Causes of Death in the United States: Comparative Risk Assessment of Dietary, Lifestyle, and Metabolic Risk Factors , 2009, PLoS medicine.

[573]  D. Wald,et al.  Combination Therapy Versus Monotherapy in Reducing Blood Pressure: Meta-analysis on 11,000 Participants from 42 Trials , 2010 .

[574]  José Antonio Velásquez Costa,et al.  Uso de espironolactona o doxazosina en pacientes con hipertensión arterial refractaria , 2009 .

[575]  R. Marshall,et al.  Modelling the potential impact of population-wide and targeted high-risk blood pressure-lowering strategies on cardiovascular disease in China , 2009, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[576]  J. Pascual,et al.  Spironolactone and doxazosin treatment in patients with resistant hypertension. , 2009, Revista espanola de cardiologia.

[577]  D. Levy,et al.  Single Versus Combined Blood Pressure Components and Risk for Cardiovascular Disease: The Framingham Heart Study , 2009, Circulation.

[578]  N. Cook,et al.  Joint effects of sodium and potassium intake on subsequent cardiovascular disease: the Trials of Hypertension Prevention follow-up study. , 2009, Archives of internal medicine.

[579]  V. Rogozov,et al.  Autoappendicectomy in the Antarctic , 2009 .

[580]  Susan Anderson,et al.  Irbesartan in patients with heart failure and preserved ejection fraction. , 2008, The New England journal of medicine.

[581]  G. Bakris,et al.  Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. , 2008, The New England journal of medicine.

[582]  K. Asayama,et al.  Masked Hypertension Determined by Self-Measured Blood Pressure at Home and Chronic Kidney Disease in the Japanese General Population: The Ohasama Study , 2008, Hypertension Research.

[583]  F. Beyer,et al.  Relaxation therapies for the management of primary hypertension in adults: a Cochrane review , 2008, Journal of Human Hypertension.

[584]  Donna M. Zulman,et al.  The relative merits of population-based and targeted prevention strategies. , 2008, The Milbank quarterly.

[585]  B. Davis,et al.  Heart Failure With Preserved and Reduced Left Ventricular Ejection Fraction in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial , 2008, Circulation.

[586]  M. Woodward,et al.  Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials. , 2008, European heart journal.

[587]  A. P. Riera,et al.  Correlation of electrocardiographic left ventricular hypertrophy criteria with left ventricular mass by echocardiogram in obese hypertensive patients. , 2008, Journal of electrocardiology.

[588]  W. White,et al.  ASH Position Paper: Home and Ambulatory Blood Pressure Monitoring
When and How to Use Self (Home) and Ambulatory Blood Pressure Monitoring , 2008, Journal of clinical hypertension.

[589]  D. de Zeeuw,et al.  Albuminuria assessed from first-morning-void urine samples versus 24-hour urine collections as a predictor of cardiovascular morbidity and mortality. , 2008, American journal of epidemiology.

[590]  P. Gosse,et al.  Ambulatory blood pressure monitoring versus self-measurement of blood pressure at home: correlation with target organ damage , 2008, Journal of hypertension.

[591]  E. Woodle,et al.  A Prospective, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial Comparing Early (7 Day) Corticosteroid Cessation Versus Long-Term, Low-Dose Corticosteroid Therapy , 2008, Annals of surgery.

[592]  M. Newman,et al.  The ECLIPSE Trials: Comparative Studies of Clevidipine to Nitroglycerin, Sodium Nitroprusside, and Nicardipine for Acute Hypertension Treatment in Cardiac Surgery Patients , 2008, Anesthesia and analgesia.

[593]  P. Miller,et al.  Blood pressure reduction during treatment for alcohol dependence: results from the Combining Medications and Behavioral Interventions for Alcoholism (COMBINE) study. , 2008, Addiction.

[594]  S. Yusuf,et al.  Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo , 2008, The Lancet Neurology.

[595]  M. Kaste,et al.  Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. , 2008, The New England journal of medicine.

[596]  A. Klatsky,et al.  Alcohol and hypertension: a review. , 2008, Journal of the American Society of Hypertension : JASH.

[597]  W. Young,et al.  Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. , 2008, The Journal of clinical endocrinology and metabolism.

[598]  N. Marshall,et al.  Sleep apnea as an independent risk factor for all-cause mortality: the Busselton Health Study. , 2008, Sleep.

[599]  C. Bulpitt,et al.  Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial , 2008, The Lancet Neurology.

[600]  C. McCulloch,et al.  Prehypertension during Young Adulthood and Coronary Calcium Later in Life , 2008, Annals of Internal Medicine.

[601]  J. Chen,et al.  Blood pressure and clinical outcome among patients with acute stroke in Inner Mongolia, China , 2008, Journal of hypertension.

[602]  F. Messerli,et al.  Secondary Hypertension: Interfering Substances , 2008, Journal of clinical hypertension.

[603]  David Goff,et al.  Call to action on use and reimbursement for home blood pressure monitoring: a joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association. , 2008, Hypertension.

[604]  M. Böhm,et al.  The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure – a prospective, randomized, controlled prevention trial of the German Hypertension League , 2008, Journal of hypertension.

[605]  Furman S. McDonald,et al.  Clinical consequences of withholding versus administering renin-angiotensin-aldosterone system antagonists in the preoperative period. , 2008, Journal of hospital medicine.

[606]  J. Ralston,et al.  Effectiveness of home blood pressure monitoring, Web communication, and pharmacist care on hypertension control: a randomized controlled trial. , 2008, JAMA.

[607]  D. Goff,et al.  Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. , 2008, Circulation.

[608]  Youfa Wang,et al.  Tracking of Blood Pressure From Childhood to Adulthood: A Systematic Review and Meta–Regression Analysis , 2008, Circulation.

[609]  E. Ofili,et al.  Hypertension in Women—Part II , 2008, Journal of clinical hypertension.

[610]  G. Bray,et al.  Weight loss and blood pressure control (Pro). , 2008, Hypertension.

[611]  Denis Xavier,et al.  Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial , 2008, The Lancet.

[612]  B Neal,et al.  Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials , 2008, BMJ : British Medical Journal.

[613]  J. Staessen,et al.  Diagnostic Thresholds for Ambulatory Blood Pressure Moving Lower: A Review Based on a Meta‐Analysis—Clinical Implications , 2008, Journal of clinical hypertension.

[614]  C. Anderson,et al.  Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial , 2008, The Lancet Neurology.

[615]  Li-sheng Liu,et al.  Treatment of hypertension in patients 80 years of age or older. , 2008, The New England journal of medicine.

[616]  V. Montori,et al.  The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. , 2008, The Journal of clinical endocrinology and metabolism.

[617]  F. Salvi,et al.  Renin–angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans , 2008, Journal of hypertension.

[618]  D. Belletti,et al.  Identifying barriers to hypertension care: implications for quality improvement initiatives. , 2008, Disease management : DM.

[619]  V. Musini,et al.  Pharmacological interventions for hypertensive emergencies: a Cochrane systematic review , 2008, Journal of Human Hypertension.

[620]  S. Yusuf,et al.  Telmisartan, ramipril, or both in patients at high risk for vascular events. , 2008, The New England journal of medicine.

[621]  T. Yamanaka,et al.  Exaggerated Hypertensive Response to Exercise in Patients with Diastolic Heart Failure , 2008, Hypertension Research.

[622]  Stacey L Sheridan,et al.  Does the routine use of global coronary heart disease risk scores translate into clinical benefits or harms? A systematic review of the literature , 2008, BMC health services research.

[623]  D. Duprez.  Systolic hypertension in the elderly: addressing an unmet need. , 2008, The American journal of medicine.

[624]  E. Brown,et al.  The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study. , 2008, Clinical therapeutics.

[625]  Chenchen Wang,et al.  The effect of tai chi exercise on blood pressure: a systematic review. , 2008, Preventive cardiology.

[626]  Kevin J. Anstrom,et al.  Incidence and prevalence of heart failure in elderly persons, 1994-2003. , 2008, Archives of internal medicine.

[627]  L. Ghiadoni,et al.  Phosphodiesterase 5 inhibition in essential hypertension , 2008, Current hypertension reports.

[628]  F. Schena,et al.  A Randomized, Multicenter Study of Steroid Avoidance, Early Steroid Withdrawal or Standard Steroid Therapy in Kidney Transplant Recipients , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[629]  B. Davis,et al.  Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). , 2008, Archives of internal medicine.

[630]  D. Levy,et al.  A Risk Score for Predicting Near-Term Incidence of Hypertension: The Framingham Heart Study , 2008, Annals of Internal Medicine.

[631]  D. Taber,et al.  Use of Renin—Angiotensin—Aldosterone System Inhibitors Within the First Eight to Twelve Weeks After Renal Transplantation , 2008, The Annals of pharmacotherapy.

[632]  Barry J. Davis,et al.  Metabolic and Clinical Outcomes in Nondiabetic Individuals With the Metabolic Syndrome Assigned to Chlorthalidone, Amlodipine, or Lisinopril as Initial Treatment for Hypertension , 2007, Diabetes Care.

[633]  I. St Gyalai-Korpos,et al.  Hypertensive acute pulmonary oedema as expression of diastolic heart failure. , 2008, Romanian journal of internal medicine = Revue roumaine de medecine interne.

[634]  M. A. Meyer.  Patent foramen ovale and cryptogenic stroke. , 2008, The New England journal of medicine.

[635]  E. Michelson,et al.  TROPHY study: Outcomes based on the Seventh Report of the Joint National Committee on Hypertension definition of hypertension. , 2008, Journal of the American Society of Hypertension : JASH.

[636]  D. Brunenberg,et al.  Self-Measurement of Blood Pressure at Home Reduces the Need for Antihypertensive Drugs: A Randomized, Controlled Trial , 2007, Hypertension.

[637]  R. Fagard,et al.  Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis , 2007, Journal of hypertension.

[638]  Jackson T. Wright,et al.  Blood Pressure Control in Hispanics in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial , 2007, Hypertension.

[639]  Lucas M Bachmann,et al.  Accuracy of electrocardiography in diagnosis of left ventricular hypertrophy in arterial hypertension: systematic review , 2007, BMJ : British Medical Journal.

[640]  T. Wilens,et al.  Impact of substance use disorder on ADHD and its treatment. , 2007, The Journal of clinical psychiatry.

[641]  S. Bangalore,et al.  Fixed-dose combinations improve medication compliance: a meta-analysis. , 2007, The American journal of medicine.

[642]  E. Ernst,et al.  Qigong for hypertension: a systematic review of randomized clinical trials , 2007, Journal of hypertension.

[643]  J. Staessen,et al.  Prognostic superiority of daytime ambulatory over conventional blood pressure in four populations: a meta-analysis of 7030 individuals , 2007, Journal of hypertension.

[644]  M. Mori,et al.  Association of ambulatory use of statins and beta-blockers with long-term mortality after vascular surgery. , 2007, Journal of hospital medicine.

[645]  J. Cutler,et al.  Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. , 2007, The American journal of cardiology.

[646]  P. Greenland,et al.  Predictive Utility of Pulse Pressure and Other Blood Pressure Measures for Cardiovascular Outcomes , 2007, Hypertension.

[647]  P. Phillips,et al.  Management outcomes of patients with type 2 diabetes: targeting the 10‐year absolute risk of coronary heart disease , 2007, The Medical journal of Australia.

[648]  Michael Bursztyn,et al.  Reproducibility of white-coat and masked hypertension in ambulatory BP monitoring. , 2007, International journal of cardiology.

[649]  S. Colman,et al.  Comparing COPD treatment: nebulizer, metered dose inhaler, and concomitant therapy. , 2007, The American journal of medicine.

[650]  T. Larson,et al.  Diurnal blood pressure changes one year after kidney transplantation: relationship to allograft function, histology, and resistive index. , 2007, Journal of the American Society of Nephrology : JASN.

[651]  Susan L Norris,et al.  Effectiveness of community health workers in the care of people with hypertension. , 2007, American journal of preventive medicine.

[652]  J. Staessen,et al.  Diagnostic Thresholds for Ambulatory Blood Pressure Monitoring Based on 10-Year Cardiovascular Risk , 2007, Circulation.

[653]  N. Cook,et al.  Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP) , 2007, BMJ : British Medical Journal.

[654]  R. Schmieder,et al.  Renin-angiotensin system and cardiovascular risk , 2007, The Lancet.

[655]  Arya M. Sharma,et al.  European Society of Hypertension Working Group on Obesity: background, aims and perspectives. , 2007, Journal of hypertension.

[656]  C. Harteneck,et al.  Increased store-operated and 1-oleoyl-2-acetyl-sn-glycerol-induced calcium influx in monocytes is mediated by transient receptor potential canonical channels in human essential hypertension , 2007, Journal of hypertension.

[657]  D. Lane,et al.  Low-dose spironolactone in the management of resistant hypertension: a surveillance study , 2007, Journal of hypertension.

[658]  R. J. Reed,et al.  Anthrax vaccination in the Millennium Cohort: validation and measures of health. , 2007, American journal of preventive medicine.

[659]  P. Whelton,et al.  Association between the metabolic syndrome and chronic kidney disease in Chinese adults. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[660]  J. Newcomer,et al.  Metabolic considerations in the use of antipsychotic medications: a review of recent evidence. , 2007, The Journal of clinical psychiatry.

[661]  Fernando Costa,et al.  Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus , 2007, Diabetes Care.

[662]  Rossella Fattori,et al.  Simple risk models to predict surgical mortality in acute type A aortic dissection: the International Registry of Acute Aortic Dissection score. , 2007, The Annals of thoracic surgery.

[663]  Giuseppe Mancia,et al.  World Health Organization (WHO) and International Society of Hypertension (ISH) risk prediction charts: assessment of cardiovascular risk for prevention and control of cardiovascular disease in low and middle-income countries. , 2007, Journal of hypertension.

[664]  Jeroen J. Bax,et al.  Increase of 1-year mortality after perioperative beta-blocker withdrawal in endovascular and vascular surgery patients. , 2007, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[665]  A. Divani,et al.  Prevalence of elevated blood pressure in 563,704 adult patients with stroke presenting to the ED in the United States. , 2007, The American journal of emergency medicine.

[666]  Keith C. Norris,et al.  Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[667]  J. Laragh,et al.  Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: an analysis of findings from the VALUE trial , 2006, Journal of hypertension.

[668]  S. Kritchevsky,et al.  The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. , 2006, The journals of gerontology. Series A, Biological sciences and medical sciences.

[669]  Satoko Nakamura,et al.  Masked hypertension and target organ damage in treated hypertensive patients. , 2006, American journal of hypertension.

[670]  B. Davis,et al.  Clinical Events in High-Risk Hypertensive Patients Randomly Assigned to Calcium Channel Blocker Versus Angiotensin-Converting Enzyme Inhibitor in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial , 2006, Hypertension.

[671]  M. Zeegers,et al.  Blood pressure response to calcium supplementation: a meta-analysis of randomized controlled trials , 2006, Journal of Human Hypertension.

[672]  D. Rizzoni,et al.  Renal Damage in Primary Aldosteronism: Results of the PAPY Study , 2006, Hypertension.

[673]  V. Roger,et al.  Trends in prevalence and outcome of heart failure with preserved ejection fraction. , 2006, The New England journal of medicine.

[674]  Vandana Sundaram,et al.  Quality Improvement Strategies for Hypertension Management: A Systematic Review , 2006, Medical care.

[675]  M. Woodward,et al.  Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial , 2006, Journal of hypertension.

[676]  C. Conti,et al.  Blood pressure control and cardiovascular outcomes in high-risk Hispanic patients--findings from the International Verapamil SR/Trandolapril Study (INVEST). , 2006, American heart journal.

[677]  S. Oparil,et al.  Feasibility of treating prehypertension with an angiotensin-receptor blocker. , 2006, The New England journal of medicine.

[678]  M. Quon,et al.  Reciprocal Relationships Between Insulin Resistance and Endothelial Dysfunction: Molecular and Pathophysiological Mechanisms , 2006, Circulation.

[679]  R. Agarwal,et al.  Prognostic importance of ambulatory blood pressure recordings in patients with chronic kidney disease. , 2006, Kidney international.

[680]  F. Cos,et al.  Home blood pressure self-monitoring: diagnostic performance in white-coat hypertension , 2006, Blood pressure monitoring.

[681]  R. Sacco,et al.  Recurrent stroke and cardiac risks after first ischemic stroke , 2006, Neurology.

[682]  A. Cheung.  Exploring an Optimum Intra/Postoperative Management Strategy for Acute Hypertension in the Cardiac Surgery Patient , 2006, Journal of cardiac surgery.

[683]  Rodney A. White,et al.  ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography , 2006, Circulation.

[684]  Matthias Briel,et al.  Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials. , 2006, Archives of internal medicine.

[685]  W. White.  Blood Pressure Monitoring enters its second decade of publication , 2006 .

[686]  Bryan Williams,et al.  Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials , 2006, Journal of hypertension.

[687]  D. Meier,et al.  The big chill--inserting the DEA into end-of-life care. , 2006, The New England journal of medicine.

[688]  N. Martell-Clarós,et al.  Efficacy of a home blood pressure monitoring programme on therapeutic compliance in hypertension: the EAPACUM–HTA study , 2006, Journal of hypertension.

[689]  I. Thompson,et al.  Erectile dysfunction and subsequent cardiovascular disease. , 2005, JAMA.

[690]  Milton C. Weinstein,et al.  Cost-Effectiveness Analysis of Hypertension Guidelines in South Africa: Absolute Risk Versus Blood Pressure Level , 2005, Circulation.

[691]  D. Battleman,et al.  Evidence‐based interventions to improve patient compliance with antihypertensive and lipid‐lowering medications , 2005, International journal of clinical practice.

[692]  G. Opelz,et al.  Improved Long‐Term Outcomes After Renal Transplantation Associated with Blood Pressure Control , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[693]  A. Rodgers,et al.  Cardiovascular medications in primary care: treatment gaps and targeting by absolute risk. , 2005, The New Zealand medical journal.

[694]  Rebecca Voelker.  Katrina's impact on mental health likely to last years. , 2005, JAMA.

[695]  A. Evangelista,et al.  Long-term vasodilator therapy in patients with severe aortic regurgitation. , 2005, The New England journal of medicine.

[696]  S Bryan,et al.  Targets and self monitoring in hypertension: randomised controlled trial and cost effectiveness analysis , 2005, BMJ : British Medical Journal.

[697]  Yutaka Imai,et al.  Prognosis of "masked" hypertension and "white-coat" hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. , 2005, Journal of the American College of Cardiology.

[698]  B. Winblad,et al.  The age-dependent relation of blood pressure to cognitive function and dementia , 2005, The Lancet Neurology.

[699]  P. Lindenauer,et al.  Perioperative beta-blocker therapy and mortality after major noncardiac surgery. , 2005, The New England journal of medicine.

[700]  D. Lloyd‐Jones,et al.  Hypertension in adults across the age spectrum: current outcomes and control in the community. , 2005, JAMA.

[701]  Yutaka Imai,et al.  White-coat hypertension as a risk factor for the development of home hypertension: the Ohasama study. , 2005, Archives of internal medicine.

[702]  T. Sanders,et al.  Comparison of efficacy of plant stanol ester and sterol ester: short-term and longer-term studies. , 2005, The American journal of cardiology.

[703]  H. Calkins,et al.  Electrocardiographic findings over time in arrhythmogenic right ventricular dysplasia/cardiomyopathy. , 2005, The American journal of cardiology.

[704]  Michael F O'Rourke,et al.  Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. , 2005, Hypertension.

[705]  T. Greene,et al.  Blood Pressure Control, Drug Therapy, and Kidney Disease , 2005, Hypertension.

[706]  Thomas D. Giles,et al.  Major clinical trials of hypertension: what should be done next? , 2005, Hypertension.

[707]  Neil Chapman,et al.  Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials. , 2005, Archives of internal medicine.

[708]  D. E. Mathis,et al.  Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). , 2005, Archives of internal medicine.

[709]  S. Yusuf,et al.  Clinical ResearchHeart Rhythm DisorderPrevention of Atrial Fibrillation With Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: A Meta-Analysis , 2005 .

[710]  F. Gueyffier,et al.  Treatment of High Blood Pressure and Gain in Event-Free Life Expectancy , 2005, Vascular health and risk management.

[711]  W. Jagust,et al.  Determinants of vascular dementia in the Cardiovascular Health Cognition Study , 2005, Neurology.

[712]  François Gueyffier,et al.  Systolic and Diastolic Blood Pressure Lowering as Determinants of Cardiovascular Outcome , 2005, Hypertension.

[713]  P. Milliez,et al.  Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. , 2005, Journal of the American College of Cardiology.

[714]  Barry R. Davis,et al.  Outcomes in Hypertensive Black and Nonblack Patients Treated With Chlorthalidone, Amlodipine, and Lisinopril , 2005 .

[715]  G. Stergiou,et al.  Comparison of antihypertensive effects of an angiotensin-converting enzyme inhibitor, a calcium antagonist and a diuretic in patients with hypertension not controlled by angiotensin receptor blocker monotherapy , 2005, Journal of hypertension.

[716]  Jose M Marin,et al.  Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study , 2005, The Lancet.

[717]  G. Beck,et al.  The Effect of a Lower Target Blood Pressure on the Progression of Kidney Disease: Long-Term Follow-up of the Modification of Diet in Renal Disease Study , 2005, Annals of Internal Medicine.

[718]  I. Kantola,et al.  Bell or diaphragm in the measurement of blood pressure? , 2005, Journal of hypertension.

[719]  G. Remuzzi,et al.  Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial , 2005, The Lancet.

[720]  P. Whelton,et al.  Effect of dietary fiber intake on blood pressure: a meta-analysis of randomized, controlled clinical trials , 2005, Journal of hypertension.

[721]  M. Nieminen,et al.  Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. , 2005, Journal of the American College of Cardiology.

[722]  Daniel W. Jones,et al.  Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. , 2005, Hypertension.

[723]  D. Grobbee,et al.  Dietary fiber and blood pressure: a meta-analysis of randomized placebo-controlled trials. , 2005, Archives of internal medicine.

[724]  Alan C. Wilson,et al.  Long-term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes. , 2005, The American journal of cardiology.

[725]  M. Nieminen,et al.  Prognostic significance of left ventricular mass change during treatment of hypertension. , 2004, JAMA.

[726]  C. Nelson-Piercy,et al.  Management of hypertension before, during, and after pregnancy , 2004, Heart.

[727]  L. Lindholm,et al.  Atenolol in hypertension: is it a wise choice? , 2004, The Lancet.

[728]  E. Ernst,et al.  Insufficient evidence to conclude whether or not Transcendental Meditation decreases blood pressure: results of a systematic review of randomized clinical trials , 2004, Journal of hypertension.

[729]  S. Senn.  Individual response to treatment: is it a valid assumption? , 2004, BMJ : British Medical Journal.

[730]  J. Kleijnen,et al.  Systematic Review: Antihypertensive Drug Therapy in Black Patients , 2004, Annals of Internal Medicine.

[731]  J. Hollander,et al.  Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath. , 2004, Journal of the American College of Cardiology.

[732]  Douglas K Owens,et al.  Closing the Quality Gap: A Critical Analysis of Quality Improvement Strategies (Vol. 2: Diabetes Care) , 2004 .

[733]  Albert Hofman,et al.  Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study. , 2004, European heart journal.

[734]  T. Ogihara,et al.  valsartan in elderly isolated systolic hypertension (VALISH) study: rationale and design. , 2004, Hypertension research : official journal of the Japanese Society of Hypertension.

[735]  Jaclyn Leblanc,et al.  Acute postoperative hypertension: a review of therapeutic options. , 2004, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[736]  B. Rosner,et al.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents , 2004 .

[737]  A. Persu,et al.  Recent insights in the development of organ damage caused by hypertension , 2004, Acta cardiologica.

[738]  P. Palatini,et al.  Prevalence and Clinical Significance of Isolated Ambulatory Hypertension in Young Subjects Screened for Stage 1 Hypertension , 2004, Hypertension.

[739]  P. Sanders,et al.  Electrophysiologic and electroanatomic changes in the human atrium associated with age. , 2004, Journal of the American College of Cardiology.

[740]  P. Ridker.  High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: from concept to clinical practice to clinical benefit. , 2004, American heart journal.

[741]  J. Laragh,et al.  Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial , 2004, The Lancet.

[742]  T. Fahey,et al.  How can we improve adherence to blood pressure-lowering medication in ambulatory care? Systematic review of randomized controlled trials. , 2004, Archives of internal medicine.

[743]  R Alagesan,et al.  Safety and efficacy of angiotensin-converting enzyme inhibitors in symptomatic severe aortic stenosis: Symptomatic Cardiac Obstruction-Pilot Study of Enalapril in Aortic Stenosis (SCOPE-AS). , 2004, American heart journal.

[744]  J. Sear,et al.  Hypertension, hypertensive heart disease and perioperative cardiac risk. , 2004, British journal of anaesthesia.

[745]  D. Goldsmith,et al.  Insights from ambulatory blood pressure monitoring: diagnosis of hypertension and diurnal blood pressure in renal transplant recipients , 2004, Transplantation.

[746]  W. Young,et al.  Increased Diagnosis of Primary Aldosteronism, Including Surgically Correctable Forms, in Centers from Five Continents , 2004 .

[747]  W. Hundley,et al.  Heart failure prevalence, incidence, and mortality in the elderly with diabetes. , 2004, Diabetes care.

[748]  C. Anderson,et al.  Ten-Year Risk of First Recurrent Stroke and Disability After First-Ever Stroke in the Perth Community Stroke Study , 2004, Stroke.

[749]  Jan A Staessen,et al.  Antihypertensive treatment based on blood pressure measurement at home or in the physician's office: a randomized controlled trial. , 2004, JAMA.

[750]  P. Rothwell,et al.  Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies , 2004, Neurology.

[751]  Jing Chen,et al.  The Metabolic Syndrome and Chronic Kidney Disease in U.S. Adults , 2004, Annals of Internal Medicine.

[752]  G. Tsivgoulis,et al.  U‐shaped relationship between mortality and admission blood pressure in patients with acute stroke , 2004, Journal of internal medicine.

[753]  Joaquín Serena,et al.  Blood Pressure Decrease During the Acute Phase of Ischemic Stroke Is Associated With Brain Injury and Poor Stroke Outcome , 2004, Stroke.

[754]  S. Yusuf,et al.  Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease , 2004 .

[755]  M. Joffe,et al.  Blood pressure and the survival of renal allografts from living donors. , 2004, Journal of the American Society of Nephrology : JASN.

[756]  G. Ansell,et al.  Outcome of ASA III patients undergoing day case surgery. , 2004, British journal of anaesthesia.

[757]  Kiang Liu,et al.  Cardiorespiratory fitness in young adulthood and the development of cardiovascular disease risk factors. , 2003, JAMA.

[758]  Daniel W. Jones,et al.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. , 2003, Hypertension.

[759]  Karl Swedberg,et al.  Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. , 2003, The New England journal of medicine.

[760]  F. Turnbull.  Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials , 2003, The Lancet.

[761]  Diederick E. Grobbee,et al.  Influence of Weight Reduction on Blood Pressure: A Meta-Analysis of Randomized Controlled Trials , 2003, Hypertension.

[762]  Santi Trimarchi,et al.  Clinical Profiles and Outcomes of Acute Type B Aortic Dissection in the Current Era: Lessons From the International Registry of Aortic Dissection (IRAD) , 2003, Circulation.

[763]  R. Giugliano,et al.  Improving antithrombotic treatment in patients after myocardial infarction , 2003, The Lancet.

[764]  Karl Swedberg,et al.  Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial , 2003, The Lancet.

[765]  K. Fox,et al.  Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study) , 2003, The Lancet.

[766]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[767]  T. Fahey,et al.  The influence of absolute cardiovascular risk, patient utilities, and costs on the decision to treat hypertension: a Markov decision analysis , 2003, Journal of hypertension.

[768]  Christopher H Schmid,et al.  Progression of Chronic Kidney Disease: The Role of Blood Pressure Control, Proteinuria, and Angiotensin-Converting Enzyme Inhibition: A Patient-Level Meta-Analysis , 2003, Annals of Internal Medicine.

[769]  L. Wilkins.  Diuretic Versus &agr;-Blocker as First-Step Antihypertensive Therapy: Final Results From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) , 2003 .

[770]  L. Magee,et al.  Oral beta-blockers for mild to moderate hypertension during pregnancy. , 2003, The Cochrane database of systematic reviews.

[771]  Ihab Hajjar,et al.  Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. , 2003, JAMA.

[772]  D. Grobbee,et al.  Blood pressure response to changes in sodium and potassium intake: a metaregression analysis of randomised trials , 2003, Journal of Human Hypertension.

[773]  N J Wald,et al.  Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials , 2003, BMJ : British Medical Journal.

[774]  L. Weinehall,et al.  Risk stratification by guidelines compared with risk assessment by risk equations applied to a MONICA sample , 2003, Journal of hypertension.

[775]  J. Healey,et al.  Atrial fibrillation: hypertension as a causative agent, risk factor for complications, and potential therapeutic target. , 2003, The American journal of cardiology.

[776]  Thomas Lumley,et al.  Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. , 2003, JAMA.

[777]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[778]  Neil Chapman,et al.  Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. , 2003, Archives of internal medicine.

[779]  Guilbert Jj.  The world health report 2002 - reducing risks, promoting healthy life. , 2003 .

[780]  A. Hofman,et al.  The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial , 2003, Journal of hypertension.

[781]  H. Bilo,et al.  Prediction of coronary heart disease: a comparison between the Copenhagen risk score and the Framingham risk score applied to a Dutch population , 2003, Journal of internal medicine.

[782]  Victor J Stevens,et al.  Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. , 2003, JAMA.

[783]  D. Bennett,et al.  Blood pressure and cardiovascular disease in the Asia Pacific region. , 2003, Journal of hypertension.

[784]  K. Digre.  Not so benign intracranial hypertension , 2003, BMJ : British Medical Journal.

[785]  John E Hall,et al.  The kidney, hypertension, and obesity. , 2003, Hypertension.

[786]  B. Strauer,et al.  Obesity and hypertension in coronary heart disease: two independent PRIMErs? , 2003, Journal of hypertension.

[787]  K. Okumura,et al.  Phospholipase C activity is enhanced in skin fibroblasts obtained from patients with essential hypertension , 2003, Journal of hypertension.

[788]  D. Henderson-smart,et al.  Drugs for treatment of very high blood pressure during pregnancy. , 2013, The Cochrane database of systematic reviews.

[789]  B. Davis,et al.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). , 2002, JAMA.

[790]  R. Collins,et al.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002, The Lancet.

[791]  R. Hoermann.  Thyroid-hormone suppressive therapy in benign thyroid nodules—is it effective? , 2002, The Lancet.

[792]  Tom Greene,et al.  Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. , 2002, JAMA.

[793]  Majid Ezzati,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .

[794]  D. Bennett,et al.  Blood pressure and coronary heart disease: a review of the evidence. , 2002, Seminars in vascular medicine.

[795]  B. Davis,et al.  Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). , 2002, Journal of clinical hypertension.

[796]  R. Brookmeyer,et al.  Survival following a diagnosis of Alzheimer disease. , 2002, Archives of neurology.

[797]  Jiang He,et al.  Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. , 2002, JAMA.

[798]  J. Gardin,et al.  Outcome of Congestive Heart Failure in Elderly Persons: Influence of Left Ventricular Systolic Function: The Cardiovascular Health Study , 2002, Annals of Internal Medicine.

[799]  Jan A Staessen,et al.  The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. , 2002, Archives of internal medicine.

[800]  G. Chatellier,et al.  The Framingham prediction rule is not valid in a European population of treated hypertensive patients , 2002, Journal of hypertension.

[801]  W. Young,et al.  Use of plasma aldosterone concentration-to-plasma renin activity ratio as a screening test for primary aldosteronism. A systematic review of the literature. , 2002, Endocrinology and metabolism clinics of North America.

[802]  Stuart R. Lipsitz,et al.  Prediction of mortality from coronary heart disease among diverse populations: is there a common predictive function? , 2002, Heart.

[803]  K. Eagle,et al.  Acute type A aortic dissection in the elderly: clinical characteristics, management, and outcomes in the current era. , 2002, Journal of the American College of Cardiology.

[804]  Jiang He,et al.  Fruit and vegetable intake and risk of cardiovascular disease in US adults: the first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. , 2002, The American journal of clinical nutrition.

[805]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[806]  S. Aronson,et al.  Isolated Systolic Hypertension Is Associated with Adverse Outcomes from Coronary Artery Bypass Grafting Surgery , 2002, Anesthesia and analgesia.

[807]  P. Sandercock,et al.  Blood Pressure and Clinical Outcomes in the International Stroke Trial , 2002, Stroke.

[808]  L. Fleisher.  Preoperative evaluation of the patient with hypertension. , 2002, JAMA.

[809]  Jiang He,et al.  Effect of Aerobic Exercise on Blood Pressure , 2002, Annals of Internal Medicine.

[810]  A. Menotti,et al.  The estimate of cardiovascular risk. Theory, tools and problems. , 2002, Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna.

[811]  J. Bosch,et al.  Use of ramipril in preventing stroke: double blind randomised trial , 2002, BMJ : British Medical Journal.

[812]  M. Nieminen,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .

[813]  L. Guize,et al.  Prognostic value of systolic and diastolic blood pressure in treated hypertensive men. , 2002, Archives of internal medicine.

[814]  P. Mehler,et al.  Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. , 2002, Kidney international.

[815]  Sudha Seshadri,et al.  Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. , 2002, JAMA.

[816]  Michel Guillot,et al.  Beyond Six Billion: Forecasting the World's Population , 2002 .

[817]  Antonio Addis,et al.  Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: evidence from a meta-analysis. , 2002, Clinical therapeutics.

[818]  Yutaka Imai,et al.  Rationale and design of HOMED-BP Study: Hypertension Objective treatment based on Measurement by Electrical Devices of Blood Pressure Study , 2002, Blood pressure monitoring.

[819]  D. Linden.  Five hundred years of brain images. , 2002, Archives of neurology.

[820]  J. Schachter,et al.  Should trachoma be treated with antibiotics? , 2002, The Lancet.

[821]  D. Henderson-smart,et al.  Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. , 2014, The Cochrane database of systematic reviews.

[822]  P. Dubbert,et al.  Exercise and hypertension , 2001, Current opinion in cardiology.

[823]  Jiang He,et al.  Effects of Alcohol Reduction on Blood Pressure: A Meta-Analysis of Randomized Controlled Trials , 2001, Hypertension.

[824]  L. Ruilope,et al.  A random comparison of fosinopril and nifedipine GITS in patients with primary renal disease , 2001, Journal of hypertension.

[825]  M. Woodward,et al.  Randomised trial of a perindopril-based blood pressure lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack , 2001 .

[826]  Roberto Sega,et al.  Alterations of Cardiac Structure in Patients With Isolated Office, Ambulatory, or Home Hypertension: Data From the General Population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study) , 2001, Circulation.

[827]  W. Bartlett,et al.  Comparative accuracy of cardiovascular risk prediction methods in patients with diabetes mellitus , 2001, Diabetes, obesity & metabolism.

[828]  J. Cramer,et al.  A systematic review of the associations between dose regimens and medication compliance. , 2001, Clinical therapeutics.

[829]  H. Soininen,et al.  Midlife vascular risk factors and late-life mild cognitive impairment , 2001, Neurology.

[830]  Keith C. Norris,et al.  Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. , 2001, JAMA.

[831]  S. Howell,et al.  Survey of cancellation rate of hypertensive patients undergoing anaesthesia and elective surgery. , 2001, British journal of anaesthesia.

[832]  B. Seifert,et al.  Chronic β-blocker therapy improves outcome and reduces treatment costs in chronic type B aortic dissection , 2001 .

[833]  S. Lemeshow,et al.  Elevated blood pressure predicts the risk of acute rejection in renal allograft recipients. , 2001, Kidney international.

[834]  Ali G. Gharavi,et al.  Molecular Mechanisms of Human Hypertension , 2001, Cell.

[835]  N. Fineberg,et al.  Salt Sensitivity, Pulse Pressure, and Death in Normal and Hypertensive Humans , 2001, Hypertension.

[836]  G. Bray,et al.  Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet , 2001 .

[837]  S. Kimmel,et al.  Perioperative β-blocker withdrawal and mortality in vascular surgical patients , 2001 .

[838]  R. Fogari,et al.  Effects of different dihydropyridine calcium antagonists on plasma norepinephrine in essential hypertension , 2000, Journal of hypertension.

[839]  C. Mulrow,et al.  MANAGEMENT OF MILD CHRONIC HYPERTENSION DURING PREGNANCY: A REVIEW , 2000, Obstetrics and gynecology.

[840]  J. Manson,et al.  Systolic and Diastolic Blood Pressure, Pulse Pressure, and Mean Arterial Pressure as Predictors of Cardiovascular Disease Risk in Men , 2000, Hypertension.

[841]  P. Donnan,et al.  The influence of physical activity on the variability of ambulatory blood pressure. , 2000, American journal of hypertension.

[842]  John S Yudkin,et al.  Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study , 2000, BMJ : British Medical Journal.

[843]  M. Hill,et al.  Development and testing of the Hill-Bone Compliance to High Blood Pressure Therapy Scale. , 2000, Progress in cardiovascular nursing.

[844]  T. Young,et al.  Prospective study of the association between sleep-disordered breathing and hypertension. , 2000, The New England journal of medicine.

[845]  L. V. Van Gaal,et al.  Overweight, obesity, and blood pressure: the effects of modest weight reduction. , 2000, Obesity research.

[846]  Bonnie K. Lind,et al.  Association of Sleep-Disordered Breathing, Sleep Apnea, and Hypertension in a Large Community-Based Study , 2000 .

[847]  D. Reda,et al.  Regional and racial differences in response to antihypertensive medication use in a randomized controlled trial of men with hypertension in the United States. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. , 2000, Archives of internal medicine.

[848]  P. Priest,et al.  Using thresholds based on risk of cardiovascular disease to target treatment for hypertension: modelling events averted and number treated , 2000, BMJ : British Medical Journal.

[849]  M. Joffe,et al.  Arterial hypertension and renal allograft survival. , 2000, JAMA.

[850]  A. Araujo,et al.  Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study. , 2000, The Journal of urology.

[851]  P. Whelton,et al.  Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification. , 2000, Hypertension.

[852]  S. Yusuf,et al.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. , 2000 .

[853]  E. Feskens,et al.  The Relation between Blood Pressure and Mortality Due to Coronary Heart Disease among Men in Different Parts of the World , 2000 .

[854]  E. Rimm,et al.  Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors , 1999, BMJ.

[855]  L. Kuhn,et al.  Infant-feeding patterns and HIV-1 transmission , 1999, The Lancet.

[856]  T. Hedner,et al.  Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study , 1999, The Lancet.

[857]  W. Aronow,et al.  Comparison of incidences of congestive heart failure in older African-Americans, Hispanics, and whites. , 1999, The American journal of cardiology.

[858]  Tomoshige Hayashi,et al.  Walking to Work and the Risk for Hypertension in Men: The Osaka Health Survey , 1999, Annals of Internal Medicine.

[859]  Aytaç,et al.  The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences , 1999, BJU international.

[860]  Nick Freemantle,et al.  β Blockade after myocardial infarction: systematic review and meta regression analysis , 1999 .

[861]  D. Levy,et al.  Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. , 1999, Journal of the American College of Cardiology.

[862]  R. D'Agostino,et al.  Clustering of metabolic factors and coronary heart disease. , 1999, Archives of internal medicine.

[863]  S. Textor,et al.  Cyclosporin-Induced Hypertension , 1999, Drug safety.

[864]  H. Geiger,et al.  Hypertension is associated with hyperlipidemia, coronary heart disease and chronic graft failure in kidney transplant recipients. , 1999, Clinical nephrology.

[865]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.

[866]  R. Devereux,et al.  Left ventricular hypertrophy in hypertension: stimuli, patterns, and consequences. , 1999, Hypertension research : official journal of the Japanese Society of Hypertension.

[867]  L. Niskanen,et al.  Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial , 1999, The Lancet.

[868]  L. Appel,et al.  Effects of dietary patterns on blood pressure: subgroup analysis of the Dietary Approaches to Stop Hypertension (DASH) randomized clinical trial. , 1999, Archives of internal medicine.

[869]  A. Rodgers,et al.  Blood pressure and the global burden of cardiovascular disease. , 1999, Clinical and experimental hypertension.

[870]  J A Staessen,et al.  Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension , 1998, Journal of hypertension.

[871]  J. Tuomilehto,et al.  Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial , 1998, The Lancet.

[872]  W C Willett,et al.  Intake of potassium, magnesium, calcium, and fiber and risk of stroke among US men. , 1998, Circulation.

[873]  Philip D. Harvey,et al.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 , 1998, BMJ.

[874]  R. Holman,et al.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. , 1998 .

[875]  R. Kronmal,et al.  High body fatness, but not low fat-free mass, predicts disability in older men and women: the Cardiovascular Health Study. , 1998, The American journal of clinical nutrition.

[876]  J. Chippaux,et al.  Meningococcal immunisation and protection from epidemics , 1998, The Lancet.

[877]  Ingmar Skoog,et al.  A Review on Blood Pressure and Ischaemic White Matter Lesions , 1998, Dementia and Geriatric Cognitive Disorders.

[878]  M. Koelemay,et al.  Can cruropedal colour duplex scanning and pulse generated run-off replace angiography in candidates for distal bypass surgery. , 1998, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[879]  Joël Ménard,et al.  Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial , 1998, The Lancet.

[880]  J. Cutler,et al.  Prevention and Treatment of Hypertension Study (PATHS): effects of an alcohol treatment program on blood pressure. , 1998, Archives of internal medicine.

[881]  W. Aronow,et al.  Normal left ventricular ejection fraction in older persons with congestive heart failure. , 1998, Chest.

[882]  P. Whelton,et al.  Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group. , 1998, JAMA.

[883]  R. Schrier,et al.  The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension. , 1998, The New England journal of medicine.

[884]  M. Aszterbaum,et al.  Book Review Genetic Skin Disorders (Oxford Monographs on Medical Genetics. No. 33.) By Virginia P. Sybert. 675 pp., illustrated. New York, Oxford University Press, 1997. $195. 0-19-506218-3 , 1998 .

[885]  F. Speizer,et al.  Body Weight, Weight Change, and Risk for Hypertension in Women , 1998, Annals of Internal Medicine.

[886]  T. Fujii,et al.  Sodium sensitivity and cardiovascular events in patients with essential hypertension , 1997, The Lancet.

[887]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[888]  Jan A Staessen,et al.  Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension , 1997, The Lancet.

[889]  P. Whelton.  Epidemiology and the Prevention of Hypertension , 1997, The Medical clinics of North America.

[890]  A. Levey,et al.  Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a meta-analysis of randomized trials. Angiotensin-Converting-Enzyme Inhibition and Progressive Renal Disease Study Group. , 1997, Annals of internal medicine.

[891]  G. Murphy.  And so to sleep… perchance? , 1997, The Lancet.

[892]  B. Davis,et al.  Prevention of Heart Failure by Antihypertensive Drug Treatment in Older Persons With Isolated Systolic Hypertension , 1997 .

[893]  W. Aronow,et al.  Effect of propranolol versus no propranolol on total mortality plus nonfatal myocardial infarction in older patients with prior myocardial infarction, congestive heart failure, and left ventricular ejection fraction > or = 40% treated with diuretics plus angiotensin-converting enzyme inhibitors. , 1997, The American journal of cardiology.

[894]  P. Whelton,et al.  Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. , 1997, JAMA.

[895]  J. Cutler,et al.  Effect of Antihypertensive Drug Treatment on Cardiovascular Outcomes in Women and Men , 1997, Annals of Internal Medicine.

[896]  G. Bray,et al.  A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. , 1997, The New England journal of medicine.

[897]  L. Ferrucci,et al.  Hospital diagnoses, Medicare charges, and nursing home admissions in the year when older persons become severely disabled. , 1997, JAMA.

[898]  N. Cook,et al.  Efficacy of nonpharmacologic interventions in adults with high-normal blood pressure: results from phase 1 of the Trials of Hypertension Prevention. Trials of Hypertension Prevention Collaborative Research Group. , 1997, The American journal of clinical nutrition.

[899]  J. Stamler,et al.  The INTERSALT Study: background, methods, findings, and implications. , 1997, The American journal of clinical nutrition.

[900]  F Beyersdorf,et al.  Endoluminal stent-grafts for infrarenal abdominal aortic aneurysms. , 1997, The New England journal of medicine.

[901]  Detection.  The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI) , 1997 .

[902]  N. Freemantle,et al.  CONSORT: An Important Step toward Evidence-Based Health Care , 1997, Annals of Internal Medicine.

[903]  R. Wiesner,et al.  Role of steroid dose in hypertension early after liver transplantation with tacrolimus (FK506) and cyclosporine. , 1996, Transplantation.

[904]  J F Toole,et al.  Presence and severity of cerebral white matter lesions and hypertension, its treatment, and its control. The ARIC Study. Atherosclerosis Risk in Communities Study. , 1996, Stroke.

[905]  K. Jamerson,et al.  The impact of ethnicity on response to antihypertensive therapy. , 1996, The American journal of medicine.

[906]  L. Fried,et al.  Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. , 1996, Stroke.

[907]  P. Elliott,et al.  Intersalt revisited: further analyses of 24 hour sodium excretion and blood pressure within and across populations , 1996 .

[908]  R. Kloner,et al.  Sex- and age-related antihypertensive effects of amlodipine , 1996 .

[909]  M. Burnier,et al.  Isolated office hypertension: a prehypertensive state? , 1996, Journal of hypertension.

[910]  M. Weinberger,et al.  Salt sensitivity of blood pressure in humans. , 1996, Hypertension.

[911]  C. Lewis,et al.  Efficacy and tolerance of antihypertensive treatment in men and women with stage 1 diastolic hypertension. Results of the Treatment of Mild Hypertension Study. , 1996, Archives of internal medicine.

[912]  P. Seib,et al.  Indexing left ventricular mass in children and adolescents. , 1996, The American journal of cardiology.

[913]  G. Boysen,et al.  Influence of systolic and diastolic blood pressure on stroke risk: a prospective observational study. , 1995, American journal of epidemiology.

[914]  Joseph P. Broderick,et al.  Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .

[915]  V. Nicaud,et al.  Improving hypertension control among excessive alcohol drinkers: a randomised controlled trial in France. The WALPA Group. , 1995, Journal of epidemiology and community health.

[916]  T. Greene,et al.  Blood Pressure Control, Proteinuria, and the Progression of Renal Disease , 1995, Annals of Internal Medicine.

[917]  D. Levy,et al.  Improved electrocardiographic detection of echocardiographic left ventricular hypertrophy: results of a correlated data base approach. , 1995, Journal of the American College of Cardiology.

[918]  P. Whelton,et al.  The contribution of urinary cations to the blood pressure differences associated with migration. , 1995, American journal of epidemiology.

[919]  M. Nicholls,et al.  High prevalence of persistent cough with angiotensin converting enzyme inhibitors in Chinese. , 1995, British journal of clinical pharmacology.

[920]  P Whelton,et al.  Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. , 1995, Hypertension.

[921]  Pats-Collaborating-Group-.  Post-stroke antihypertensive treatment study. A preliminary result , 1995 .

[922]  G. Mancia,et al.  Sympathetic activation in obese normotensive subjects. , 1995, Hypertension.

[923]  P Whelton,et al.  Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. , 1995, Hypertension.

[924]  N. Cook,et al.  The effect of potassium supplementation in persons with a high-normal blood pressure. Results from phase I of the Trials of Hypertension Prevention (TOHP). Trials of Hypertension Prevention (TOHP) Collaborative Research Group. , 1995, Annals of epidemiology.

[925]  A. House,et al.  Short-term and long-term outcome following renovascular reconstruction. , 1995, Cardiovascular surgery.

[926]  R. Prineas,et al.  Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS). , 1995, Circulation.

[927]  G. Bray.  Life insurance and overweight. , 1995, Obesity research.

[928]  Daniel W. Jones,et al.  Body mass index and blood pressure in Korean men and women: the Korean National Blood Pressure Survey , 1994, Journal of hypertension.

[929]  C. Begg,et al.  Operating characteristics of a rank correlation test for publication bias. , 1994, Biometrics.

[930]  H. Parving,et al.  Prevalence of Arterial Hypertension in Diabetic Patients Before and After the JNC-V , 1994, Diabetes Care.

[931]  W. Applegate,et al.  Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program. , 1994, Archives of internal medicine.

[932]  L. Fried,et al.  Self‐Reported Causes of Physical Disability in Older People: The Cardiovascular Health Study , 1994, Journal of the American Geriatrics Society.

[933]  S. Rahimtoola,et al.  Nifedipine in asymptomatic patients with severe aortic regurgitation and normal left ventricular function. , 1994, The New England journal of medicine.

[934]  S. Redline,et al.  Assessment of the validity and utility of a sleep-symptom questionnaire. , 1994, American journal of respiratory and critical care medicine.

[935]  G. Beck,et al.  The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease , 1994 .

[936]  Changing physicians' behavior. , 1994 .

[937]  C. Lewis,et al.  Treatment of Mild Hypertension Study: Final Results , 1993 .

[938]  J. Cutler,et al.  Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group. , 1993, JAMA.

[939]  Jeremiah Stamler,et al.  Blood Pressure, Systolic and Diastolic, and Cardiovascular Risks: US Population Data , 1993 .

[940]  S. Wolfsthal.  Is blood pressure control necessary before surgery? , 1993, The Medical clinics of North America.

[941]  J. Neaton,et al.  Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial , 1993, Diabetes Care.

[942]  E. J. Brown,et al.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.

[943]  T. Vogt,et al.  Home Blood Pressure Monitoring: Effect on Use of Medical Services and Medical Care Costs , 1992, Medical care.

[944]  N. Cook,et al.  The Effects of Nonpharmacologic Interventions on Blood Pressure of Persons With High Normal Levels: Results of the Trials of Hypertension Prevention, Phase I , 1992 .

[945]  M. Johns,et al.  A new method for measuring daytime sleepiness: the Epworth sleepiness scale. , 1991, Sleep.

[946]  R. Mattes,et al.  Relative contributions of dietary sodium sources. , 1991, Journal of the American College of Nutrition.

[947]  S. Watanabe,et al.  Prognosis of patients with medically treated aortic dissections. , 1991, Circulation.

[948]  P. Wilson,et al.  The epidemiology of impaired glucose tolerance and hypertension. , 1991, American heart journal.

[949]  G. Tell,et al.  Effect of Migration on Blood Pressure: The Yi People Study , 1991, Epidemiology.

[950]  G. Tell,et al.  Relation of Electrolytes to Blood Pressure in Men The Yi People Study , 1991, Hypertension.

[951]  L. Midanik,et al.  Home blood pressure monitoring for mild hypertensives. , 1991, Public health reports.

[952]  S. Nattel,et al.  Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research Group. , 1991, Circulation.

[953]  B. Massie,et al.  A Comparison of the Efficacy and Safety of a β-Blocker, a Calcium Channel Blocker, and a Converting Enzyme Inhibitor in Hypertensive Blacks , 1990 .

[954]  J. Gold,et al.  The preoperative and intraoperative hemodynamic predictors of postoperative myocardial infarction or ischemia in patients undergoing noncardiac surgery. , 1989, Annals of surgery.

[955]  A. Haines,et al.  Randomised controlled trial of general practitioner intervention in patients with excessive alcohol consumption. , 1988, BMJ.

[956]  G. Scally.  Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Intersalt Cooperative Research Group. , 1988, BMJ.

[957]  Jeremiah Stamler,et al.  Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Intersalt Cooperative Research Group. , 1988 .

[958]  L. Kuller,et al.  Mortality associated with diastolic hypertension and isolated systolic hypertension among men screened for the Multiple Risk Factor Intervention Trial. , 1988, Circulation.

[959]  J. Laragh,et al.  How common is white coat hypertension? , 1988, JAMA.

[960]  R. Newson,et al.  Beta adrenoceptor blockade is associated with increased survival in male but not female hypertensive patients: a report from the DHSS Hypertension Care Computing Project (DHCCP). , 1986, Journal of human hypertension.

[961]  E. Barrett-Connor,et al.  The association between blood pressure, age, and dietary sodium and potassium: a population study. , 1988, Circulation.

[962]  W. Kannel,et al.  Incidence and precursors of hypertension in young adults: the Framingham Offspring Study. , 1987, Preventive medicine.

[963]  N. Fineberg,et al.  Definitions and Characteristics of Sodium Sensitivity and Blood Pressure Resistance , 1986, Hypertension.

[964]  C. Bulpitt,et al.  Mortality and Morbidity Results from the European Working Party on High Blood Pressure in the Elderly Trial , 1985, The Lancet.

[965]  A. Marshall,et al.  Abrupt withdrawal of atenolol in patients with severe angina: comparison with the effects of treatment. , 1986, British heart journal.

[966]  N. Poulter,et al.  Blood pressure and associated factors in a rural Kenyan community. , 1984, Hypertension.

[967]  W. Castelli,et al.  Epidemiology of coronary heart disease: the Framingham study. , 1984, The American journal of medicine.

[968]  M. Sokolow,et al.  The prognostic value of ambulatory blood pressures. , 1983, JAMA.

[969]  Manning Feinleib,et al.  Obesity as an Independent Risk Factor for Cardiovascular Disease: A 26‐year Follow‐up of Participants in the Framingham Heart Study , 1983, Circulation.

[970]  N. Madias,et al.  Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenoses or renal-artery stenosis in a solitary kidney. , 1983, The New England journal of medicine.

[971]  S. Langlois,et al.  Comparison of withdrawal phenomena after propranolol, metoprolol and pindolol. , 1982, British journal of clinical pharmacology.

[972]  R. Anderson,et al.  Withdrawal syndromes and the cessation of antihypertensive therapy. , 1981, Archives of internal medicine.

[973]  R. Bonow,et al.  Clinical efficacy of verapamil alone and combined with propranolol in treating patients with chronic stable angina pectoris. , 1981, The American journal of cardiology.

[974]  T. Dawber.  The Framingham Study: The Epidemiology of Atherosclerotic Disease , 1980 .

[975]  Towne Jb,et al.  The relationship of postoperative hypertension to complications following carotid endarterectomy. , 1980 .

[976]  W. Aronow,et al.  The Effect of Timolol vs Placebo on Angina Pectoris , 1980, Circulation.

[977]  D. Tashkin,et al.  Sites of airway dilatation in asthma following inhaled versus subcutaneous terbutaline. Comparison of physiologic tests with radionuclide lung images. , 1980, The American journal of medicine.

[978]  J. Gerber,et al.  Abrupt withdrawal of cardiovascular drugs. , 1979, The New England journal of medicine.

[979]  D. Stanski,et al.  CURARE NEUROMUSCULAR BLOCKADE DURING HYPOTHERMIA IN MAN , 1979 .

[980]  L. Goldman,et al.  Risks of General Anesthesia and Elective Operation in the Hypertensive Patient , 1979, Anesthesiology.

[981]  Iqbal Krishan,et al.  Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. A cooperative study. , 1977, JAMA.

[982]  L. Wilhelmsen,et al.  Prevalence of primary and secondary hypertension: studies in a random population sample. , 1976, British medical journal.

[983]  S. Rössner,et al.  Effects of the cardioselective beta-adrenergic receptor blocking agent metoprolol in angina pectoris. Subacute study with exercise tests. , 1976, British heart journal.

[984]  P. Foëx,et al.  Studies of anaesthesia in relation to hypertension. 3. Pulmonary gas exchange during spontaneous ventilation. , 1971, British journal of anaesthesia.

[985]  Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. , 1967, JAMA.

[986]  H. Miller.  CLINICAL PSYCHIATRY FOR THE LAYMAN , 1964 .

[987]  N. Kaplan,et al.  Hypogonadism in young men (with emphasis on Klinefelter's syndrome). , 1961, Annals of internal medicine.

[988]  C. C. Jones.  Pulmonary alveolar proteinosis with unusual complicating infections; a report of two cases. , 1960, The American journal of medicine.

[989]  Gifford Rw.  Current practices in general medicine. 7. Treatment of hypertensive emergencies including use of sodium nitroprusside. , 1959 .

[990]  M. Perlstein.  Congenital morphinism; a rare cause of convulsions in the newborn. , 1947, Journal of the American Medical Association.

[991]  N. M. Keith,et al.  Some different types of essential hypertension: their course and prognosis. , 1939 .

[992]  I. Greenwald.  METABOLISM IN PNEUMONIA: II. THE MECHANISM OF THE RETENTION OF CHLORIDE IN PNEUMONIA , 1931 .

[993]  N. S. Davis.  POLYCYTHEMIA VERA (VAQUEZ-OSLER DISEASE): GOUT ANGULATION OF THE LEFT URETER WITH BEGINNING LEFT HYDRONEPHROSIS , 1929 .

[994]  J. Treadwell.  A Case of Fibro-Plastic Tumor of the Base of the Skull, Associated with Leucocythæmic Changes in the Blood and Several Glandular Organs , 1869 .

[995]  Cyrus Falconer.  Cæsarean Operation on a Dwarf , 1843 .